Dennis W. Dickson
#56,228
Most Influential Person Now
Researcher
Dennis W. Dickson's AcademicInfluence.com Rankings
Dennis W. Dicksonengineering Degrees
Engineering
#960
World Rank
#1496
Historical Rank
Electrical Engineering
#99
World Rank
#115
Historical Rank
Dennis W. Dicksoncomputer-science Degrees
Computer Science
#1853
World Rank
#1924
Historical Rank
Computational Linguistics
#8
World Rank
#8
Historical Rank
Machine Learning
#77
World Rank
#77
Historical Rank
Database
#122
World Rank
#125
Historical Rank
Download Badge
Engineering Computer Science
Dennis W. Dickson's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Dennis W. Dickson Influential?
(Suggest an Edit or Addition)Dennis W. Dickson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (6818)
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS (2011) (4089)
- Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 (1998) (3363)
- Diagnosis and management of dementia with Lewy bodies (2005) (3346)
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology (2004) (2782)
- Clinical diagnostic criteria for dementia associated with Parkinson's disease (2007) (2413)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. (1996) (2280)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) (1996) (2138)
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012) (2093)
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2011) (1839)
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 (2006) (1809)
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP (2001) (1580)
- Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. (2001) (1424)
- Criteria for the diagnosis of corticobasal degeneration (2013) (1198)
- Genome-wide analysis of genetic loci associated with Alzheimer disease. (2010) (1177)
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria (2017) (1150)
- The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease (2007) (1112)
- Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein (2000) (1105)
- Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease (1997) (1105)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- The neuropathological diagnosis of Alzheimer’s disease (2019) (1027)
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (2007) (1007)
- Primary age-related tauopathy (PART): a common pathology associated with human aging (2014) (988)
- Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS (2013) (944)
- Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force (2007) (918)
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update (2009) (869)
- Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. (2007) (860)
- Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease (1993) (858)
- Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease (1996) (843)
- Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. (1993) (829)
- Association of an extended haplotype in the tau gene with progressive supranuclear palsy. (1999) (756)
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease (2007) (748)
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study (2011) (713)
- The Pathogenesis of Senile Plaques (1997) (712)
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (2009) (711)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. (2005) (665)
- CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation (2004) (652)
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) (646)
- The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy (2015) (639)
- Identification of normal and pathological aging in prospectively studied nondemented elderly humans (1992) (633)
- Neuropathology of Cognitively Normal Elderly (2003) (629)
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease (2009) (621)
- ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function (2015) (620)
- Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications (2004) (606)
- Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. (2006) (602)
- The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. (2007) (593)
- Pathology of Neurodegenerative Diseases. (2017) (593)
- Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank (2002) (591)
- Neuropathologic features of amnestic mild cognitive impairment. (2006) (589)
- Parkinson's disease and parkinsonism: neuropathology. (2012) (584)
- Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration (2002) (580)
- The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging (1999) (578)
- Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia (2002) (564)
- A neuronal antigen in the brains of Alzheimer patients. (1986) (564)
- Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy (2004) (552)
- Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) (552)
- Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. (2006) (539)
- Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity (2009) (534)
- Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo (2003) (487)
- Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy (2011) (481)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain (1997) (468)
- Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice (2010) (464)
- Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS (2013) (464)
- The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families (1995) (461)
- Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy (2007) (458)
- Mutations in the colony stimulating factor 1 receptor (CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids (2011) (442)
- Clinico‐pathologic studies in dementia (1988) (442)
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup (2011) (441)
- Correlations of synaptic and pathological markers with cognition of the elderly (1995) (436)
- Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis (2008) (433)
- Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP (2006) (423)
- TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics (2017) (422)
- Genetic evidence for the involvement of τ in progressive supranuclear palsy (1997) (417)
- ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43 (2014) (416)
- Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. (2012) (414)
- Pathology and Biology of the Lewy Body (1993) (413)
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations (2008) (398)
- Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. (1988) (397)
- Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. (2002) (392)
- Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype (2001) (387)
- An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016) (383)
- Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics (2012) (372)
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2019) (372)
- Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43 (2007) (371)
- Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. (2004) (371)
- Neuropathological background of phenotypical variability in frontotemporal dementia (2011) (368)
- Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism (2003) (356)
- Neuropathology underlying clinical variability in patients with synucleinopathies (2011) (352)
- DLB and PDD boundary issues (2007) (351)
- Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members (2009) (348)
- Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease (2008) (343)
- Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (341)
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
- Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ (1993) (339)
- Colocalization of Tau and Alpha‐Synuclein Epitopes in Lewy Bodies (2003) (338)
- C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits (2015) (336)
- Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study (2012) (336)
- HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology (1991) (335)
- MRI correlates of neurofibrillary tangle pathology at autopsy (2008) (335)
- A yeast functional screen predicts new candidate ALS disease genes (2011) (327)
- TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD (2017) (327)
- Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease (2000) (325)
- Neuropathology of Parkinson disease. (2018) (318)
- Age-specific and Sex-specific Prevalence and Incidence of Mild Cognitive Impairment, Dementia, and Alzheimer Dementia in Blacks and Whites: A Report From the Einstein Aging Study (2012) (313)
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease (2013) (311)
- Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. (2006) (310)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. (2013) (307)
- TDP-43 is a key player in the clinical features associated with Alzheimer’s disease (2014) (307)
- Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS (2015) (306)
- Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease (2009) (299)
- Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease (1991) (298)
- Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 (2011) (297)
- Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease (2004) (295)
- Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias (2014) (295)
- Aβ40 Inhibits Amyloid Deposition In Vivo (2007) (291)
- Translation initiator EIF4G1 mutations in familial Parkinson disease. (2011) (290)
- Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia (2008) (289)
- DCTN1 mutations in Perry syndrome (2009) (286)
- Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. (1988) (285)
- Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition (2010) (285)
- Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. (1991) (284)
- Neuropathology of variants of progressive supranuclear palsy. (2010) (283)
- Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. (1991) (277)
- Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress (2014) (277)
- Widespread cytoskeletal pathology characterizes corticobasal degeneration. (1995) (276)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Neurodegenerative disorders with extensive tau pathology: A comparative study and review (1996) (273)
- Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter (2001) (272)
- Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy (2006) (271)
- Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum (2015) (270)
- A novel human disease with abnormal prion protein sensitive to protease (2008) (270)
- DNAJC13 mutations in Parkinson disease. (2014) (269)
- Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration (1996) (267)
- Widespread Alterations of α-Synuclein in Multiple System Atrophy (1999) (267)
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) (2011) (267)
- Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases (2016) (266)
- Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration (1999) (266)
- Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (2011) (265)
- Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood (2013) (265)
- Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. (2009) (263)
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (262)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- Lrrk2 and Lewy body disease (2006) (260)
- Autosomal dominant parkinsonism associated with variable synuclein and tau pathology (2004) (258)
- Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease (2015) (255)
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice (2010) (254)
- Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. (2010) (253)
- Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration (2005) (251)
- DLB fluctuations (2004) (249)
- AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies (2011) (248)
- When DLB, PD, and PSP masquerade as MSA (2015) (247)
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study (2011) (246)
- C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD (2015) (245)
- Neuropathology of non-motor features of Parkinson disease. (2009) (243)
- Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. (2015) (243)
- C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins (2016) (242)
- Staging TDP-43 pathology in Alzheimer’s disease (2014) (238)
- Caught in the Act α-Synuclein Is the Culprit in Parkinson's Disease (2003) (238)
- Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species (2006) (235)
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study (2013) (235)
- The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. (2013) (233)
- Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants (2012) (232)
- Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy (2002) (232)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (230)
- Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank (2015) (227)
- Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice (2015) (224)
- Suspected non-Alzheimer disease pathophysiology — concept and controversy (2016) (224)
- Progressive Supranuclear Palsy: Pathology and Genetics (2007) (222)
- Progranulin in frontotemporal lobar degeneration and neuroinflammation (2007) (222)
- Reactive nitrogen intermediates in human neuropathology: an overview. (1994) (222)
- Replication of CLU, CR1, and PICALM associations with alzheimer disease. (2010) (221)
- Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype (2008) (219)
- Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease (2014) (219)
- Updated TDP-43 in Alzheimer’s disease staging scheme (2016) (218)
- Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative (2007) (218)
- β‐amyloid burden is not associated with rates of brain atrophy (2008) (216)
- GM‐CSF promotes proliferation of human fetal and adult microglia in primary cultures (1994) (215)
- Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry (2007) (215)
- Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance (2013) (214)
- Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains (2020) (214)
- Voxel-based morphometry in autopsy proven PSP and CBD (2008) (214)
- An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. (2006) (212)
- Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. (1990) (210)
- Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity (1998) (209)
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. (2012) (208)
- Variably protease‐sensitive prionopathy: A new sporadic disease of the prion protein (2010) (207)
- Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. (1990) (204)
- Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis (2018) (202)
- Parkinsonism, Lrrk2 G2019S, and tau neuropathology (2006) (201)
- Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? (2004) (200)
- Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes (1999) (200)
- A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity (2016) (198)
- Corticobasal degeneration: a pathologically distinct 4R tauopathy (2011) (197)
- Multiple System Atrophy: A Sporadic Synucleinopathy (1999) (197)
- Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/- Knock-Out Mice (2003) (196)
- Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis (2017) (196)
- Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid (2018) (195)
- Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. (1996) (195)
- Antemortem diagnosis of frontotemporal lobar degeneration (2005) (194)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice (2015) (191)
- Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. (2010) (188)
- Imaging correlates of pathology in corticobasal syndrome (2010) (187)
- Mitotic phosphoepitopes precede paired helical filaments in Alzheimer’s disease (1998) (186)
- Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies (2014) (185)
- Neuropsychological Differentiation of Dementia with Lewy Bodies from Normal Aging and Alzheimer's Disease (2006) (184)
- Tau gene mutation in familial progressive subcortical gliosis (1999) (184)
- Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. (1994) (184)
- Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p (2000) (182)
- Multimodality imaging characteristics of dementia with Lewy bodies (2012) (180)
- Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations (2007) (180)
- Neurofilament inclusion body disease: a new proteinopathy? (2003) (180)
- TDP-43 in aging and Alzheimer's disease - a review. (2011) (180)
- Stroke in pediatric acquired immunodeficiency syndrome (1990) (179)
- Microglial Activation Parallels System Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration (2001) (178)
- Incidental Lewy body disease and preclinical Parkinson disease. (2008) (177)
- Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias (2014) (176)
- Prominent phenotypic variability associated with mutations in Progranulin (2009) (176)
- Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies (2013) (175)
- β-Amyloid Degradation and Alzheimer's Disease (2006) (175)
- Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. (1990) (175)
- Cholesterol Accumulates in Senile Plaques of Alzheimer Disease Patients and in Transgenic APPsw Mice (2001) (174)
- Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. (2005) (173)
- Pick's Disease: A Modern Approach (1998) (172)
- Pathological markers associated with normal aging and dementia in the elderly (1993) (172)
- Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. (2016) (172)
- AIDS: Calcification of the basal ganglia in infants and children (1986) (170)
- LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors (2012) (170)
- Regional synaptic pathology in Alzheimer's disease (1992) (170)
- Antemortem diagnosis of diffuse Lewy body disease (1990) (170)
- Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. (1987) (169)
- Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies (2015) (168)
- Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage (2008) (168)
- Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. (2008) (166)
- IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice (2010) (165)
- Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease (2011) (165)
- Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia (2005) (164)
- Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia (2014) (164)
- Ataxin-2 repeat-length variation and neurodegeneration. (2011) (164)
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
- Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies (2017) (162)
- Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease (2008) (162)
- CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia (2016) (160)
- Abeta40 inhibits amyloid deposition in vivo. (2007) (159)
- Alpha-synuclein and the Lewy body disorders. (2001) (158)
- Dementia with Lewy bodies (2004) (158)
- Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy (2015) (157)
- Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. (2007) (157)
- Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies (1997) (157)
- Expression and functional profiling of neprilysin, insulin‐degrading enzyme, and endothelin‐converting enzyme in prospectively studied elderly and Alzheimer’s brain (2010) (156)
- Functional impact of white matter hyperintensities in cognitively normal elderly subjects. (2010) (156)
- Novel late-onset Alzheimer disease loci variants associate with brain gene expression (2012) (155)
- Evaluation of α-synuclein immunohistochemical methods used by invited experts (2008) (155)
- Globular glial tauopathies (GGT): consensus recommendations (2013) (155)
- Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice (2011) (155)
- Rates of cerebral atrophy differ in different degenerative pathologies. (2006) (154)
- High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. (2005) (154)
- Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. (1987) (152)
- Macrophage colony-stimulating factor in human fetal astrocytes and microglia. Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia. (1993) (152)
- Validation of the Neuropathologic Criteria of the Third Consortium for Dementia With Lewy Bodies for Prospectively Diagnosed Cases (2008) (150)
- Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. (1992) (150)
- Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. (2007) (148)
- Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity (2019) (147)
- Progressive aphasia secondary to Alzheimer disease vs FTLD pathology (2008) (146)
- Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? (2005) (145)
- Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank (2003) (145)
- Immunocytochemical Studies of Atherosclerotic Lesions of Cerebral Berry Aneurysms (1994) (142)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- Frequency of tau mutations in three series of non‐Alzheimer's degenerative dementia (1999) (140)
- CSF1R mutations link POLD and HDLS as a single disease entity (2013) (139)
- Two distinct subtypes of right temporal variant frontotemporal dementia (2009) (136)
- Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy‐verified sample (1999) (136)
- Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. (2004) (135)
- Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration (2009) (134)
- Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease (1998) (134)
- TDP-43 in differential diagnosis of motor neuron disorders (2007) (133)
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease (2015) (131)
- Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? (2011) (131)
- CNS small vessel disease (2019) (130)
- White-matter integrity on DTI and the pathologic staging of Alzheimer's disease (2017) (130)
- Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease (2008) (129)
- Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau (2003) (128)
- Extensive FUS‐Immunoreactive Pathology in Juvenile Amyotrophic Lateral Sclerosis with Basophilic Inclusions (2010) (128)
- (Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation (2015) (128)
- Autosomal dominant Parkinson's disease caused by SNCA duplications. (2016) (127)
- TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014) (127)
- Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia (2009) (126)
- Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration (2006) (125)
- Evidence in favor of Braak staging of Parkinson's disease (2010) (125)
- Anatomical localization of leucine-rich repeat kinase 2 in mouse brain (2006) (124)
- Oxidized neprilysin in aging and Alzheimer's disease brains. (2003) (124)
- A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease (2007) (124)
- α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals (2006) (123)
- Widespread alterations of alpha-synuclein in multiple system atrophy. (1999) (123)
- Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility (2002) (123)
- A genome-wide association study in multiple system atrophy (2016) (122)
- Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology. (2007) (122)
- Cockayne Syndrome in Adults: Review With Clinical and Pathologic Study of a New Case (2006) (120)
- Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases (2008) (120)
- Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation (2010) (119)
- Differential clinicopathologic and genetic features of late-onset amnestic dementias (2014) (118)
- Familial and sporadic Alzheimer's disease (1996) (117)
- Atrophy of superior cerebellar peduncle in progressive supranuclear palsy (2003) (116)
- Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits. (2013) (115)
- [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration (2016) (114)
- Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies (2015) (113)
- Interleukin-1, Nitric Oxide and Reactive Astrocytes (1995) (113)
- Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism (1994) (112)
- Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations (2002) (111)
- Neuropathology of non-Alzheimer degenerative disorders. (2010) (111)
- Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. (2006) (111)
- FUS is Phosphorylated by DNA-PK and Accumulates in the Cytoplasm after DNA Damage (2014) (111)
- Neuropathology of Alzheimer's disease and other dementias. (2001) (110)
- Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome (2005) (110)
- Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. (1999) (110)
- Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation (1991) (110)
- Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts (2016) (110)
- Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia (2012) (109)
- Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. (2006) (109)
- Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes (2009) (109)
- Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis (2011) (108)
- TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A (2021) (108)
- Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress‐induced neuronal death (2011) (108)
- Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study (2017) (107)
- Differential incorporation of tau isoforms in Alzheimer's disease. (2008) (107)
- Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD) (2009) (107)
- Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy (2014) (106)
- Iron and reactive oxygen species activity in parkinsonian substantia nigra. (2010) (106)
- Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ɛ4 (2003) (106)
- The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II (2007) (106)
- Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. (1993) (106)
- Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART) (2017) (105)
- BRI2 (ITM2b) Inhibits Aβ Deposition In Vivo (2008) (105)
- Neuropathology of Pick’s disease (2001) (104)
- Association of Crossword Puzzle Participation with Memory Decline in Persons Who Develop Dementia (2011) (103)
- Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimers Disease (2006) (103)
- Dementia with Lewy bodies (2014) (102)
- Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. (2011) (102)
- Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains (2012) (101)
- First appraisal of brain pathology owing to A30P mutant alpha‐synuclein (2010) (101)
- Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72 (2015) (101)
- Brain CHIP: removing the culprits in neurodegenerative disease. (2007) (100)
- Rapid eye movement sleep behavior disorder and subtypes in autopsy‐confirmed dementia with Lewy bodies (2012) (100)
- Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease. (2014) (100)
- Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels (2014) (100)
- Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes (2008) (99)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies (2006) (99)
- Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction (2003) (98)
- Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND (2011) (97)
- Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. (2006) (97)
- Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. (2011) (97)
- Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases (2018) (96)
- Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process (2002) (96)
- Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. (1994) (96)
- APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology (2018) (96)
- The dardarin G2019S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases (2005) (96)
- Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. (2003) (96)
- Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice. (2003) (95)
- Recommendations of the Alzheimer's Disease–Related Dementias Conference (2014) (95)
- Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. (2003) (95)
- Contribution of vascular pathology to the clinical expression of dementia (2010) (94)
- Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. (2005) (94)
- TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features (2015) (93)
- Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred (2006) (93)
- Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers (2015) (93)
- Argyrophilic Grain Disease: Neuropathology, Frequency in a Dementia Brain Bank and Lack of Relationship with Apolipoprotein E (2002) (92)
- Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype (2012) (92)
- Alzheimer's Disease–Related Dementias Summit 2016: National research priorities (2017) (91)
- Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration (2006) (91)
- Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments (2010) (91)
- Caudate atrophy on MRI is a characteristic feature of FTLD‐FUS (2010) (90)
- Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. (1987) (90)
- Apolipoprotein E genotype and Lewy body disease (1995) (90)
- The neuropathology and biochemistry of frontotemporal dementia (2003) (90)
- Pallidonigral TDP-43 pathology in Perry syndrome. (2009) (89)
- Risk factors for dementia with Lewy bodies (2013) (89)
- Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. (2008) (89)
- The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy (2003) (89)
- Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly (2010) (88)
- Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease (2008) (88)
- Tau-positron emission tomography correlates with neuropathology findings (2019) (88)
- Analysis of tauopathies with transgenic mice. (2001) (88)
- Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression (2019) (87)
- MRI characteristics and scoring in HDLS due to CSF1R gene mutations (2012) (87)
- Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease (2016) (86)
- Monoclonal antibodies to Alzheimer neurofibrillary tangles. 1. Identification of polypeptides. (1985) (86)
- Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion (2013) (86)
- Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy. (2009) (86)
- Tau and Synuclein and Their Role in Neuropathology (1999) (86)
- APOE ε2 is associated with increased tau pathology in primary tauopathy (2018) (86)
- Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease (1994) (86)
- Profile of cognitive impairment and underlying pathology in multiple system atrophy (2017) (85)
- Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy (2019) (85)
- Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. (1990) (85)
- C9ORF72 repeat expansions in cases with previously identified pathogenic mutations (2013) (85)
- Localization of morphologically distinct microglial populations in the developing human fetal brain: implications for ontogeny. (1990) (84)
- Glycation and microglial reaction in lesions of Alzheimer's disease (1996) (84)
- Update on the Neuropathological Diagnosis of Frontotemporal Dementias (2001) (84)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. (2007) (83)
- Single‐dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy (2007) (83)
- Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. (1996) (83)
- Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. (2012) (83)
- Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification (1997) (82)
- Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy (2005) (82)
- LRRK2 phosphorylates novel tau epitopes and promotes tauopathy (2013) (82)
- Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging. (2005) (82)
- Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies (2003) (82)
- Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers (2014) (82)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy (2020) (81)
- TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease (2012) (81)
- Cryptococcus neoformans survive and replicate in human microglia. (1995) (81)
- IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION (2007) (81)
- Productive infection of human fetal microglia by HIV-1. (1993) (81)
- Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases. (2001) (81)
- An acetylation–phosphorylation switch that regulates tau aggregation propensity and function (2017) (80)
- Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. (2009) (80)
- TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia (2013) (79)
- Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND (2005) (78)
- Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy (2017) (78)
- Long-read sequencing across the C9orf72 ‘GGGGCC’ repeat expansion: implications for clinical use and genetic discovery efforts in human disease (2018) (78)
- Parkinson’s disease: experimental models and reality (2017) (78)
- Hippocampal Sclerosis in the Elderly: Genetic and Pathologic Findings, Some Mimicking Alzheimer Disease Clinically (2011) (78)
- Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques (2004) (78)
- Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients (2017) (78)
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2019) (77)
- Frontotemporal dementia with the V337M MAPT mutation (2017) (77)
- Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. (1995) (77)
- Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. (1985) (77)
- Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? (2010) (76)
- Frontal Lobe Dementia With Novel Tauopathy: Sporadic Multiple System Tauopathy With Dementia (2001) (76)
- Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes (2004) (76)
- Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain (1998) (76)
- Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications (2012) (75)
- Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies (2008) (75)
- Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor (2012) (75)
- The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I (2007) (75)
- Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis (2012) (75)
- Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. (2014) (75)
- Multinucleated giant cells in acquired immunodeficiency syndrome encephalopathy. Origin from endogenous microglia? (1986) (74)
- Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites (2013) (74)
- Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases (2016) (74)
- Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. (2007) (74)
- Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy (2001) (74)
- Immunohistochemical localization of an HIV epitope in cerebral aneurysmal arteriopathy in pediatric acquired immunodeficiency syndrome (AIDS). (1989) (74)
- Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy (2019) (74)
- Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients (2014) (74)
- Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease. (2015) (74)
- Analysis of COQ2 gene in multiple system atrophy (2014) (74)
- A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. (2012) (73)
- Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): A misdiagnosed disease entity (2012) (73)
- Normal cognition in transgenic BRI2-Aβ mice (2013) (73)
- The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy (2021) (72)
- Polysomnographic Findings in Dementia With Lewy Bodies (2013) (72)
- Neuropathology of primary restless leg syndrome: Absence of specific τ‐ and α‐synuclein pathology (2004) (72)
- Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. (2004) (71)
- Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A (2014) (71)
- Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies (2012) (71)
- Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration (2014) (71)
- 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration (2019) (70)
- Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases (2005) (70)
- APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid (2020) (68)
- In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers (2017) (68)
- Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia (2017) (68)
- Clinical correlates of the pathology underlying parkinsonism: A population perspective (2002) (68)
- Progressive Nonfluent Aphasia and Subsequent Aphasic Dementia Associated with Atypical Progressive Supranuclear Palsy Pathology (2003) (68)
- Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease (2010) (68)
- Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. (2004) (67)
- A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry. (1989) (67)
- Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease (2016) (67)
- Imaging Signatures of Molecular Pathology in Behavioral Variant Frontotemporal Dementia (2011) (67)
- Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease (2002) (67)
- TYROBP genetic variants in early-onset Alzheimer's disease (2016) (67)
- Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein (2015) (67)
- Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease. (2013) (67)
- Argyrophilic grains: A distinct disease or an additive pathology? (2008) (67)
- Interferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification (2011) (66)
- Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder (2012) (66)
- Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study (2011) (66)
- The lysosomal protein cathepsin L is a progranulin protease (2017) (66)
- A novel calcium‐binding protein is associated with tau proteins in tauopathy (2008) (66)
- APOE4-mediated amyloid-&bgr; pathology depends on its neuronal receptor LRP1 (2019) (66)
- Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. (2011) (66)
- Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. (2003) (66)
- Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease (2018) (66)
- Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates (2017) (66)
- Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes (2017) (65)
- Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. (2006) (65)
- Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis (2004) (65)
- Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. (2001) (64)
- Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. (1996) (64)
- Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. (2008) (64)
- Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline (2004) (64)
- TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. (2016) (64)
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
- Modified Bielschowsky and Immunocytochemical Studies on Cerebellar Plaques in Alzheimer's Disease (1990) (63)
- Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. (2010) (63)
- Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease (2018) (63)
- Neuropathologic differences by race from the National Alzheimer's Coordinating Center (2016) (63)
- Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease (2010) (63)
- Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. (2020) (62)
- Microglia in cerebellar plaques in Alzheimer's disease (2004) (62)
- Glial cell inclusions and the pathogenesis of neurodegenerative diseases. (2004) (62)
- Caught in the act: alpha-synuclein is the culprit in Parkinson's disease. (2003) (62)
- Receptors for Advanced Glycosylation Endproducts in Human Brain: Role in Brain Homeostasis (1998) (62)
- Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (62)
- Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. (2009) (62)
- Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. (2010) (62)
- Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) (61)
- Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease. (2006) (61)
- Cotton Wool Plaques in Non‐Familial Late‐Onset Alzheimer Disease (2001) (61)
- Neuronal nitric oxide synthase expression in developing and adult human CNS. (1999) (61)
- Selective Neurofibrillary Degeneration of the Hippocampal CA2 Sector Is Associated with Four‐Repeat Tauopathies (2002) (61)
- Prosaposin is a regulator of progranulin levels and oligomerization (2016) (61)
- Late-onset Alzheimer disease risk variants mark brain regulatory loci (2015) (60)
- Cytokine expression and microglial activation in progressive supranuclear palsy. (2011) (60)
- Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. (2007) (60)
- Genome-wide association interaction analysis for Alzheimer's disease (2014) (60)
- Central nervous system pathology in pediatric AIDS: an autopsy study. (1989) (59)
- A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. (2002) (59)
- Characterization of DCTN1 genetic variability in neurodegeneration (2009) (59)
- ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans (2018) (59)
- Arguing against the proposed definition changes of PD (2016) (58)
- Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C (2016) (58)
- Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury. (1989) (58)
- FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis (2018) (58)
- Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells (2015) (58)
- Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease (1997) (58)
- A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. (2007) (58)
- Alzheimer's disease presenting as corticobasal syndrome (2006) (57)
- Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease (2021) (57)
- Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease (1998) (57)
- Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology (2013) (57)
- Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. (2005) (57)
- Frontotemporal lobar degeneration without lobar atrophy. (2006) (57)
- Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions (2007) (57)
- Ageing and dementia (2008) (57)
- MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies (2013) (56)
- Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids (2008) (56)
- Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease (2010) (56)
- Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates (2013) (56)
- Diffuse Lewy body disease (2004) (56)
- Leflunomide-associated progressive multifocal leukoencephalopathy. (2008) (56)
- SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia (2014) (55)
- Cognitive profile of LRRK2‐related Parkinson's disease (2015) (55)
- Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy? (2008) (55)
- Association of common KIBRA variants with episodic memory and AD risk (2011) (55)
- Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease (2004) (55)
- Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy (2011) (55)
- Non-plaque dystrophic dendrites in Alzheimer hippocampus: a new pathological structure revealed by glutamate receptor immunocytochemistry (1997) (55)
- Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders (2015) (55)
- Symmetric corticobasal degeneration (S-CBD). (2010) (54)
- Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components (1995) (54)
- A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration (2004) (54)
- Monoclonal antibodies to purified cortical lewy bodies recognize the mid‐size neurofilament subunit (1997) (54)
- α-Synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy (2004) (54)
- Increased Frequency of Argyrophilic Grain Disease in Alzheimer Disease with 4R Tau-Specific Immunohistochemistry (2005) (54)
- FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants (2014) (54)
- Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation (2013) (54)
- Spinal cord pathology in pediatric acquired immunodeficiency syndrome (1989) (54)
- Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. (1993) (54)
- Defining neurodegeneration on Guam by targeted genomic sequencing (2015) (54)
- Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains (2019) (53)
- CSF1R-related leukoencephalopathy (2018) (53)
- Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. (2013) (53)
- Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study (2014) (53)
- The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies (2018) (53)
- Reduction of Aβ accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidylinositol kinase inhibitor wortmannin (2001) (53)
- Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains (2016) (53)
- Association of Apolipoprotein E &egr;4 With Transactive Response DNA-Binding Protein 43 (2018) (53)
- Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. (2013) (53)
- Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions (2008) (53)
- Jump from pre-mutation to pathologic expansion in C9orf72. (2015) (52)
- Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease (2004) (52)
- Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease (2018) (52)
- Dementia with Lewy Bodies: Neuropathology (2002) (52)
- DCTN1-related neurodegeneration: Perry syndrome and beyond. (2017) (52)
- C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. (2012) (52)
- Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice (2004) (51)
- Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process (2006) (51)
- Reply to: SNCA variants are associated with increased risk of multiple system atrophy (2010) (51)
- Human immunodeficiency virus within the brains of children with AIDS. (1990) (51)
- Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction (2012) (51)
- Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease (2008) (51)
- Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α‐synuclein pathology (2017) (51)
- Chronic Traumatic Encephalopathy Pathology in Multiple System Atrophy (2016) (51)
- Morphological and Biochemical Correlations of Abnormal Tau Filaments in Progressive Supranuclear Palsy (2002) (51)
- Interphase Cytogenetics for 1p19q and t(1;19)(q10;p10) may Distinguish Prognostically Relevant Subgroups in Extraventricular Neurocytoma (2009) (50)
- Cerebral Granular Cell Tumor: Immunohistochemical and Electron Microscopic Study (1986) (50)
- Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration (2007) (50)
- MR imaging of brainstem atrophy in progressive supranuclear palsy (2007) (50)
- Antemortem MRI findings associated with microinfarcts at autopsy (2014) (50)
- Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites. (1993) (50)
- Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study (2019) (50)
- Neurodegeneration involving putative respiratory neurons in Perry syndrome (2008) (50)
- Cytoskeletal Alterations in Human Fetal Astrocytes Induced by Interleukin‐1β (1994) (49)
- Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody (1995) (49)
- TARDBP mutations in Parkinson's disease. (2013) (49)
- Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer’s disease presenting as logopenic progressive aphasia (2013) (49)
- Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau. (2004) (49)
- An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology (2012) (49)
- Argyrophilic Grain Disease in Demented Subjects Presenting Initially With Amnestic Mild Cognitive Impairment (2006) (48)
- Medulloblastoma with Glial and Rhabdomyoblastic Differentiation A Myoglobin and Glial Fibrillary Acidic Protein Immunohistochemical and Ultrastructural Study (1983) (48)
- Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model (2015) (48)
- PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease (2015) (48)
- MRI Correlates of Protein Deposition and Disease Severity in Postmortem Frontotemporal Lobar Degeneration (2009) (48)
- Frontotemporal Dementia Mimicking Dementia With Lewy Bodies (2008) (48)
- Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. (2008) (48)
- Transactivation Response DNA-Binding Protein 43 Microvasculopathy in Frontotemporal Degeneration and Familial Lewy Body Disease (2009) (47)
- Accumulation of Intracellular Amyloid-β Peptide (Aβ 1–40) in Mucopolysaccharidosis Brains (1999) (47)
- DEMENTIA WITH LEWY BODIES (2004) (47)
- Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD (2014) (47)
- A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression (2016) (47)
- Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. (1996) (46)
- Glucocerebrosidase mutations in diffuse Lewy body disease. (2011) (46)
- FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression (2009) (45)
- Microglia in Alzheimer's disease and transgenic models. How close the fit? (1999) (45)
- Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy (2004) (45)
- Elucidating the genetics and pathology of Perry syndrome (2010) (45)
- ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD (2019) (45)
- Amyloid angiopathy in diffuse Lewy body disease (1992) (44)
- Genetic Screening and Functional Characterization of PDGFRB Mutations Associated with Basal Ganglia Calcification of Unknown Etiology (2014) (44)
- ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease (2014) (44)
- Hippocampal Sclerosis and Ubiquitin-Positive Inclusions in Dementia Lacking Distinctive Histopathology (2004) (44)
- Reduced somatostatin‐like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia (1987) (44)
- Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations (2011) (44)
- Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test (2014) (44)
- A Qualitative and Quantitative Study of Grumose Degeneration in Progressive Supranuclear Palsy (2000) (44)
- Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). (2007) (44)
- Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's pathology (2016) (44)
- Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site (2004) (43)
- Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease (2019) (43)
- Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci (2016) (43)
- The ups and downs of α‐synuclein mRNA expression (2007) (43)
- Duration and Pathologic Correlates of Lewy Body Disease (2017) (43)
- Ossified blood vessels in primary familial brain calcification elicit a neurotoxic astrocyte response (2019) (43)
- Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia (2014) (43)
- Glucosidase-beta variations and Lewy body disorders. (2009) (43)
- Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype (2018) (42)
- Meige syndrome in the spectrum of Lewy body disease (1994) (42)
- Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease. (2014) (42)
- Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study (2020) (42)
- Neuroimmunology of Alzheimer's disease: A conference report (1992) (42)
- Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls (2001) (42)
- Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau (2005) (42)
- LRRK2 exonic variants and risk of multiple system atrophy (2014) (42)
- Creutzfeldt–Jakob disease presenting as progressive supranuclear palsy (2004) (42)
- Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy (2018) (41)
- CT appearance of primary CNS lymphoma in patients with acquired immunodeficiency syndrome. (1991) (41)
- An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease (2017) (41)
- The effect of tau genotype on clinical features in FTDP-17. (2005) (41)
- A novel tau mutation, p.K317N, causes globular glial tauopathy (2015) (41)
- APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy (2003) (41)
- The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals (2019) (41)
- Atypical parkinsonian syndromes: a general neurologist's perspective (2018) (41)
- Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy (2017) (41)
- Deposition of Alzheimer’s vascular amyloid-β is associated with decreased expression of brain l-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB) (2001) (41)
- Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry (2016) (41)
- Cellular and pathological heterogeneity of primary tauopathies (2021) (41)
- Gerstmann‐Sträussler‐Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients (1995) (41)
- Altered Expression of Zonula Occludens-2 Precedes Increased Blood–Brain Barrier Permeability in a Murine Model of Fulminant Hepatic Failure (2008) (41)
- Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies (2014) (40)
- Coexistent Lewy body disease in a case of “visual variant of Alzheimer’s disease” (2003) (40)
- Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling (2019) (40)
- Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. (1995) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Nonvasculitic autoimmune inflammatory meningoencephalitis (2004) (40)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease (2018) (39)
- ATP13A2 variability in Parkinson disease (2009) (39)
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (39)
- Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium (2013) (39)
- A double-labeling immunohistochemical study of tau exon 10 in Alzheimer’s disease, progressive supranuclear palsy and Pick’s disease (2000) (39)
- Neuropathology and molecular diagnosis of Synucleinopathies (2021) (39)
- Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies (2010) (39)
- Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration (2017) (39)
- PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. (2019) (39)
- Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. (2014) (38)
- Coexistence of PSP and MSA: a case report and review of the literature (2006) (38)
- TDP-43 in neurodegenerative disorders (2008) (38)
- Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci (2018) (38)
- Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS (2021) (38)
- C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy (2019) (38)
- Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP‐17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer’s disease (2006) (38)
- Astrocytes and microglia in human brain share an epitope recognized by a B-lymphocyte-specific monoclonal antibody (LN-1). (1989) (38)
- β-Amyloid PET and neuropathology in dementia with Lewy bodies (2019) (37)
- Lrrk2 R1441 substitution and progressive supranuclear palsy (2006) (37)
- Ubiquitin Immunohistochemistry of Frontotemporal Lobar Degeneration Differentiates Cases With and Without Motor Neuron Disease (2005) (37)
- Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. (2009) (37)
- Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165 (1995) (37)
- Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. (2007) (37)
- A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis (2007) (37)
- Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD (2013) (37)
- Neuropathology of Alzheimer's Disease and its Variants (2011) (37)
- Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. (2004) (37)
- Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis (2012) (37)
- Familial idiopathic basal ganglia calcification: a challenging clinical–pathological correlation (2009) (36)
- Corticobasal Degeneration and Frontotemporal Dementia Presentations in a Kindred with Nonspecific Histopathology (2002) (36)
- Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) (36)
- Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36 (2020) (36)
- Cognitive impairment in progressive supranuclear palsy is associated with tau burden (2017) (36)
- In situ hybridization for detection of nocardial 16S rRNA: reactivity within intracellular inclusions in experimentally infected cynomolgus monkeys—and in Lewy body-containing human brain specimens (2003) (36)
- Identification of proteins in human substantia nigra (2008) (36)
- Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation. (2001) (36)
- Linking selective vulnerability to cell death mechanisms in Parkinson's disease. (2007) (36)
- Early Onset Familial Alzheimer Disease With Spastic Paraparesis, Dysarthria, and Seizures and N135S Mutation in PSEN1 (2008) (36)
- Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat (2005) (35)
- Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease (2019) (35)
- Establishing diagnostic criteria for Perry syndrome (2017) (35)
- Clinical and neuropathological features of ALS/FTD with TIA1 mutations (2017) (35)
- Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants (2019) (35)
- Research goals in progressive supranuclear palsy (2000) (35)
- Neuropathologic and molecular considerations. (2000) (35)
- TDP-43 Pathology in Alzheimer’s Disease (2021) (35)
- Rates of cerebral atrophy in autopsy‐confirmed progressive supranuclear palsy (2006) (34)
- Macrophages and microglia in HIV-related CNS neuropathology. (1994) (34)
- Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43 (2022) (33)
- Extracellular Deposits of Aβ Produced in Cultures of Alzheimer Disease Brain Vascular Smooth Muscle Cells (2005) (33)
- Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. (2007) (33)
- Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. (2013) (33)
- Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors. (1999) (33)
- Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia. (2014) (33)
- Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer’s disease? (2014) (33)
- Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG) (2017) (32)
- Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology. (2019) (32)
- The ups and downs of alpha-synuclein mRNA expression. (2007) (32)
- α-Synuclein and the Lewy body disorders (2001) (32)
- Apoptosis in the brain. Physiology and pathology. (1995) (32)
- The Distribution and Biochemical Properties of a Cdc2‐Related Kinase, KKIALRE, in Normal and Alzheimer Brains (1995) (32)
- MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies (2016) (32)
- Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography (2015) (31)
- Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease. (2012) (31)
- Levodopa‐nonresponsive Lewy body parkinsonism (1992) (31)
- Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution (2020) (31)
- Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations (2017) (31)
- Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. (1999) (31)
- Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia (2013) (31)
- Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories (2015) (31)
- Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome (2019) (31)
- Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations. (2013) (31)
- Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies (2015) (31)
- Structure-based inhibitors halt prion-like seeding by Alzheimer's disease–and tauopathy–derived brain tissue samples (2019) (31)
- Myoclonus from selective dentate nucleus degeneration in type 3 Gaucher disease. (2000) (30)
- Tau immunoreactivity and SDS solubility of two populations of paired helical filaments that differ in morphology (1994) (30)
- TDP‐43 pathology in multiple system atrophy: colocalization of TDP‐43 and α‐synuclein in glial cytoplasmic inclusions (2018) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Ubiquitin‐immunoreactive Dystrophic Neurites in Down's Syndrome Brains (1991) (30)
- Neuropathology of hippocampal sclerosis. (2008) (30)
- Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. (2006) (30)
- Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration. (2019) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies (2019) (30)
- Transmission of Soluble and Insoluble &agr;-Synuclein to Mice (2015) (30)
- LRRK2 variation and dementia with Lewy bodies. (2016) (29)
- The TMEM106B locus and TDP-43 pathology in older persons without FTLD (2015) (29)
- Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations (2004) (29)
- Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic mice (2006) (29)
- Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy (2017) (29)
- Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72 (2013) (29)
- In vivo binding of a tau imaging probe, [11C]PBB3, in patients with progressive supranuclear palsy (2019) (29)
- Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway (1997) (29)
- Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy. (2020) (29)
- Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies. (2020) (29)
- Deciphering cellular transcriptional alterations in Alzheimer’s disease brains (2020) (29)
- Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. (2006) (29)
- Diffuse Lewy body disease manifesting as corticobasal syndrome (2018) (29)
- Klüver‐Bucy syndrome and amyotrophic lateral sclerosis (1986) (29)
- Neuronal intranuclear inclusion disease is genetically heterogeneous (2020) (29)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- The Neuropathology of Dementia: Sporadic tauopathies: Pick's disease, corticobasal degeneration, progressive supranuclear palsy and argyrophilic grain disease (2004) (28)
- FRONTOTEMPORAL LOBAR DEGENERATION WITH UPPER MOTOR NEURON DISEASE/ PRIMARY LATERAL SCLEROSIS (2007) (28)
- Extending the clinicopathological spectrum of neurofilament inclusion disease (2005) (28)
- The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments. (1991) (28)
- Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity (2004) (28)
- Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin‐deficient mice (2020) (28)
- Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases (2022) (28)
- Localization of microglia in the human fetal cervical spinal cord. (1992) (28)
- A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease (1994) (28)
- Hexanucleotide Repeat Expansions in c9FTD/ALS and SCA36 Confer Selective Patterns of Neurodegeneration In Vivo. (2020) (28)
- Heterodimerization of Lrrk1–Lrrk2: Implications for LRRK2-associated Parkinson disease (2010) (27)
- Familial Primary Progressive Aphasia (2003) (27)
- Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers (2020) (27)
- Etiology and Pathophysiology of Autistic Behavior: Clues From Two Cases With an Unusual Variant of Neuroaxonal Dystrophy (2001) (27)
- Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease (2017) (27)
- Quantitative PCR-based screening of α-synuclein multiplication in multiple system atrophy (2007) (27)
- Divergent Phenotypes in Mutant TDP-43 Transgenic Mice Highlight Potential Confounds in TDP-43 Transgenic Modeling (2014) (27)
- Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations (2020) (27)
- Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers (2019) (27)
- Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons (2016) (27)
- Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease (2021) (27)
- A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease (2015) (27)
- Building a more perfect beast: APP transgenic mice with neuronal loss. (2004) (26)
- Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts (2022) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Primitive plaques and memory dysfunction in normal and impaired elderly persons. (1987) (26)
- Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis (2013) (26)
- Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s disease (2018) (26)
- Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy (2020) (26)
- Meningioangiomatosis: an immunocytochemical study (2004) (26)
- APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) (26)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
- C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells (2016) (25)
- Lewy body variant (1990) (25)
- Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease (2014) (25)
- Association and heterogeneity at the GAPDH locus in Alzheimer's disease (2012) (25)
- Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy. (2004) (25)
- Productive Infection of Human Fetal Microglia in Vitro by HIV‐1 a (1993) (25)
- Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
- Gliomatosis cerebri presenting with hydrocephalus and dementia. (1988) (25)
- Multiple Calcifying Pseudoneoplasms of the Neuraxis (2017) (25)
- Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. (2011) (25)
- Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease (2021) (25)
- TDP-43 immunoreactivity in neurodegenerative disorders: disease versus mechanism specificity (2007) (25)
- Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. (2020) (25)
- Cardiac and skeletal myopathy in beta myosin heavy-chain simian virus 40 tsA58 transgenic mice. (1994) (25)
- Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. (2008) (25)
- Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD) (2006) (25)
- Paired helical filaments in corticobasal degeneration: the fine fibrillary structure with NanoVan (1997) (25)
- Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy (2013) (25)
- Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion (2019) (25)
- A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration (2015) (25)
- AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation (2021) (25)
- Abnormal expression of laminin beta 1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. (1997) (24)
- Striatonigral degeneration, olivopontocerebellar atrophy and „atypical” Pick disease (2004) (24)
- REM Sleep Behavior Disorder in Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy (2003) (24)
- Screening for neurofilament inclusion disease using α-internexin immunohistochemistry (2005) (24)
- ABCA7 loss-of-function variants, expression, and neurologic disease risk (2017) (24)
- Atypical Motor and Behavioral Presentations of Alzheimer Disease: A Case-based Approach (2012) (24)
- Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease. (2014) (24)
- Progranulin gene mutation with an unusual clinical and neuropathologic presentation (2008) (24)
- Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism (2002) (24)
- Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer’s disease (2020) (24)
- Adult‐onset cerebello‐brainstem dominant form of X‐linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review (2016) (24)
- Cytoskeletal abnormalities in neuropathology (1986) (24)
- TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration (2021) (24)
- Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia (2013) (23)
- TMEM106B haplotypes have distinct gene expression patterns in aged brain (2018) (23)
- Age and apoE associations with complex pathologic features in Alzheimer's disease (2008) (23)
- Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial (2017) (23)
- MAPT haplotype diversity in multiple system atrophy. (2016) (23)
- The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of β-amyloid angiopathy (CAA) (2003) (23)
- Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations (1999) (23)
- Tau exhibits unique seeding properties in globular glial tauopathy (2019) (23)
- Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort (2019) (23)
- Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer’s Disease and APPswe/PS1dE9 Double Transgenic Mice Brains (2016) (23)
- Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain (2017) (23)
- Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. (2005) (23)
- Alpha-synuclein studies are negative in postencephalic parkinsonism of von Economo. (2002) (23)
- Family history of dementia is a risk factor for Lewy body disease (2006) (22)
- DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients (2015) (22)
- Unusual patterns of Histoplasma capsulatum meningitis and progressive multifocal leukoencephalopathy in a patient with the acquired immunodeficiency virus. (1992) (22)
- Decreases in soluble α-synuclein in frontal cortex correlate with cognitive decline in the elderly (2004) (22)
- Sensitivity–Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration (2020) (22)
- Oxidative protein damage in cells engaged in &bgr;-amyloidosis is related to apoE genotype (2002) (22)
- The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease (2002) (22)
- Vascular dementia: clinical, neuroradiologic and neuropathologic aspects. (2007) (22)
- The relationship between histopathological features of progressive supranuclear palsy and disease duration. (2006) (22)
- Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy (2013) (22)
- Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. (2007) (22)
- Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model (2014) (21)
- Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus. (2013) (21)
- Alpha‐synuclein immunohistochemistry in two cases of co‐occurring idiopathic Parkinson's disease and motor neuron disease (2005) (21)
- Heterogeneous inclusions in neurofilament inclusion disease (2006) (21)
- Clinical Features and Survival of 3R and 4R Tauopathies Presenting as Behavioral Variant Frontotemporal Dementia (2007) (21)
- Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17 (2002) (21)
- Histones facilitate α-synuclein aggregation during neuronal apoptosis (2017) (21)
- Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. (2008) (21)
- Hereditary diffuse leukoencephalopathy with spheroids: ultrastructural and immunoelectron microscopic studies. (2010) (21)
- Identification of G-Protein Coupled Receptor Kinase 2 in Paired Helical Filaments and Neurofibrillary Tangles (2006) (21)
- Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients (2018) (21)
- Pathology of PD in monozygotic twins with a 20-year discordance interval (2001) (20)
- Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease (2018) (20)
- Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro (2022) (20)
- TDP-43 in Alzheimer’s disease is not associated with clinical FTLD or Parkinsonism (2014) (20)
- Tremor in progressive supranuclear palsy. (2016) (20)
- Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology (2020) (20)
- Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study (2021) (20)
- Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes. (2000) (20)
- RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies (2016) (20)
- Hippocampal sclerosis dementia (2004) (20)
- Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (2018) (19)
- A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech (2021) (19)
- Right temporal variant frontotemporal dementia with motor neuron disease (2012) (19)
- TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia. (2018) (19)
- Beta-amyloid deposition and paired helical filament formation: Which histopathological feature is more significant in Alzheimer's disease? (1989) (19)
- CHCHD 2 and Parkinson ' s disease (2015) (19)
- Aging is neuroprotective during global ischemia but leads to increased caspase-3 and apoptotic activity in hippocampal neurons. (2006) (19)
- Solitary midbrain toxoplasmosis and olivary hypertrophy in a patient with acquired immunodeficiency syndrome. (1989) (19)
- Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies (2020) (19)
- Astrocyte-derived clusterin suppresses amyloid formation in vivo (2020) (19)
- Microglia in HIV-related CNS neuropathology: an update. (1995) (19)
- TREM2 p.R47H substitution is not associated with dementia with Lewy bodies (2016) (19)
- Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia. (2016) (19)
- Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder. (2004) (18)
- Perivascular neuritic dystrophy associated with cerebral amyloid angiopathy in Alzheimer's disease. (2008) (18)
- Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease. (2002) (18)
- Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity (2018) (18)
- Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino terminal tau epitopes in GVB (2004) (18)
- Corticobasal syndrome with Alzheimer's disease pathology (2009) (18)
- Immunoelectron Microscopic and Biochemical Studies of Caspase-Cleaved Tau in a Mouse Model of Tauopathy (2011) (18)
- Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD (2021) (18)
- LRRK2 p.Ile1371Val Mutation in a Case with Neuropathologically Confirmed Multi-System Atrophy. (2018) (18)
- Pathological diagnostic criteria for dementia associated with cortical Lewy bodies: review and proposal for a descriptive approach. (1997) (18)
- microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP) (2016) (18)
- Neuropathological substrate of mild cognitive impairment (2000) (18)
- α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species (2020) (18)
- The clinicopathologic spectrum of Lewy body disease. (1996) (17)
- Evaluating pathogenic dementia variants in posterior cortical atrophy (2016) (17)
- Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies (2021) (17)
- Regional distribution of tyrosine hydroxylase and dopamine beta-hydroxylase activities in guinea pig heart. (1981) (17)
- Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism (2014) (17)
- Neuropathology of progressive supranuclear palsy. (2008) (17)
- Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease (2021) (17)
- Parkinson's disease susceptibility variants and severity of Lewy body pathology. (2017) (17)
- Familial Alzheimer's disease and cortical Lewy bodies: is there a genetic susceptibility factor? (1995) (17)
- The effect of oxidative stress on amyloid precursor protein processing in cells engaged in β-amyloidosis is related to apolipoprotein E genotype (2004) (17)
- NONHEREDITARY DIFFUSE LEUKOENCEPHALOPATHY WITH SPHEROIDS PRESENTING AS EARLY-ONSET, RAPIDLY-PROGRESSIVE DEMENTIA: 240 (1995) (17)
- In Human Fetal Astrocytes Exposure to Interleukin‐1β Stimulates Acquisition of the GD3+ Phenotype and Inhibits Cell Division (1995) (16)
- Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy (2004) (16)
- Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert. (2018) (16)
- Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggests a role for progranulin in successful aging (2010) (16)
- Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples (2020) (16)
- The AD tau core spontaneously self-assembles and recruits full-length tau to filaments (2021) (16)
- Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy. (2019) (16)
- Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40 (2020) (16)
- A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
- Induction of vascular amyloidosis-β by oxidative stress depends on APOE genotype (2006) (16)
- Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd Edition (2011) (16)
- Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease (2017) (16)
- Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology (2013) (16)
- Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy (2020) (16)
- Relationships between typical histopathological hallmarks and the ferritin in the hippocampus from patients with Alzheimer's disease. (2015) (16)
- Multiple prion types in the same brain (1999) (15)
- Brain calcifications and PCDH12 variants (2017) (15)
- Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer’s disease pathology (2005) (15)
- Aberrant Accumulation of BRCA1 in Alzheimer Disease and Other Tauopathies. (2019) (15)
- CHCHD2 and Parkinson's disease (2015) (15)
- Familial Progressive Supranuclear Palsy: A Literature Review (2013) (15)
- Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology (2017) (15)
- Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa (2019) (15)
- Hippocampal progenitor cells express nestin following cerebral ischemia in rats (2005) (15)
- Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease (2020) (15)
- Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations (2019) (14)
- Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-&bgr;42 in Alzheimer’s disease (2017) (14)
- Distinct subcellular patterns of neprilysin protein and activity in the brains of Alzheimer's disease patients, transgenic mice and cultured human neuronal cells. (2013) (14)
- Multiple system atrophy and apolipoprotein E (2018) (14)
- UBIQUITIN IMMUNOREACTIVE STRUCTURES IN NORMAL BRAINS: DISTRIBUTION AND DEVELOPMENTAL ASPECTS (1990) (14)
- Discovery of new lesions in neurodegenerative diseases with monoclonal antibody techniques: is there a non-amyloid precursor to senile plaques? (1997) (14)
- Biochemical characterization of torsinB. (2004) (14)
- p62 Pathology Model in the Rat Substantia Nigra with Filamentous Inclusions and Progressive Neurodegeneration (2017) (14)
- Pick’s disease: clinicopathologic characterization of 21 cases (2020) (14)
- Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1 (2018) (14)
- Multiplication of the α-synuclein gene is not a common disease mechanism in Lewy body disease (2007) (14)
- Phosphorylated p38MAPK specific antibodies cross‐react with sarkosyl‐insoluble hyperphosphorylated tau proteins (2004) (14)
- Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS (2013) (14)
- Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility (2015) (14)
- Pick body-like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease (2004) (13)
- Deep Learning-Based Image Classification in Differentiating Tufted Astrocytes, Astrocytic Plaques, and Neuritic Plaques. (2021) (13)
- Microglial nodule encephalitis: limited CNS infection despite disseminated systemic cryptococcosis. (1996) (13)
- Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation (2020) (13)
- FTDP‐17 with Pick body‐like inclusions associated with a novel tau mutation, p.E372G (2017) (13)
- Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
- Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration (2021) (13)
- Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau. (2013) (13)
- Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS". (2019) (13)
- Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy (2019) (13)
- Single-cell profiling of the human primary motor cortex in ALS and FTLD (2021) (13)
- LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD) (2013) (13)
- SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19 (2022) (13)
- Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype (2020) (13)
- GBA variation and susceptibility to multiple system atrophy. (2020) (12)
- Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation (2022) (12)
- Replication of EPHA 1 and CD 33 associations with late-onset Alzheimer ’ s disease : a multi-centre case-control study (2011) (12)
- 1.003 FACILITATING CLINICAL RESEARCH: THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS (NINDS) AND STROKE PARKINSON'S DISEASE COMMON DATA ELEMENTS PROJECT (2012) (12)
- Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers (2017) (12)
- Dementia with Lewy Bodies: Cytoskeletal and Alzheimer-type pathology in Lewy body disease (1996) (12)
- LRP10 in α-synucleinopathies (2018) (12)
- APOE 4-mediated amyloid-b pathology depends on its neuronal receptor LRP 1 (2019) (12)
- Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy. (2009) (12)
- Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension (2019) (12)
- A new transthyretin mutation associated with leptomeningeal amyloidosis (2011) (12)
- TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy (2021) (11)
- Effect Modifiers of TDP-43 Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes. (2020) (11)
- Microglial involvement in the acquired immunodeficiency syndrome (AIDS). (1994) (11)
- Pallidonigroluysian atrophy associated with p.A152T variant in MAPT. (2013) (11)
- Effect of MAPT and APOE on prognosis of progressive supranuclear palsy (2006) (11)
- ELECTRON MICROSCOPY 2 . 2 Å resolution cryo-EM structure of β-galactosidase in complex with a cell-permeant inhibitor (2015) (11)
- Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases (2021) (11)
- Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids (2021) (11)
- Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease (2020) (11)
- C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation (2019) (11)
- Anatomy of disturbed sleep in pallido‐ponto‐nigral degeneration (2011) (11)
- Induction of vascular amyloidosis-beta by oxidative stress depends on APOE genotype. (2006) (11)
- Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia (2016) (11)
- Featured Articles National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012) (11)
- Corticobasal degeneration -- clinico-pathological considerations. (2006) (11)
- IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION. Authors' reply (2008) (11)
- Clinicopathological and 123I‐FP‐CIT SPECT correlations in patients with dementia (2018) (10)
- Immunohistochemistry Actin-binding Proteins Coronin-1 a and IBA-1 are Effective Microglial Markers for (2007) (10)
- Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains (2012) (10)
- Prominent auditory deficits in primary progressive aphasia: A case study (2019) (10)
- “Minimal change” multiple system atrophy with limbic-predominant α-synuclein pathology (2018) (10)
- Dopamine β-hydroxylase deficiency involves the central autonomic network (2006) (10)
- Iron in Alzheimer's and control hippocampi - Mössbauer, atomic absorption and ELISA studies (2011) (10)
- Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders (2020) (10)
- ANTEMORTEM MEMORY IMPAIRMENT SCREEN PERFORMANCE IS CORRELATED WITH POSTMORTEM ALZHEIMER PATHOLOGY (2003) (10)
- Genome-wide association study and functional validation implicates JADE1 in tauopathy (2021) (10)
- Juvenile onset Parkinsonism with "pure nigral" degeneration and POLG1 mutation. (2016) (10)
- Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer’s disease: a case-control study (2020) (9)
- APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology (2022) (9)
- The Value of Cross Sectional Neuroanatomical Studies as a Conceptual Framework for Prospective Clinicopathological Studies (1997) (9)
- 18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies (2020) (9)
- Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease. (2004) (9)
- Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration (2022) (9)
- Investigating statistical epistasis in complex disorders. (2011) (9)
- LRP10 in α-synucleinopathies (2018) (9)
- Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy. (2017) (9)
- The temporal onset of the core features in dementia with Lewy bodies (2021) (9)
- Central Nervous System in Pediatric AIDS: Results from Neuropathologic Pediatric AIDS Registry a (1993) (9)
- Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy (2021) (9)
- Regional localization of the regulatory subunit (RIIβ) of the type II cAMP-dependent protein kinase in human brain (1992) (9)
- Association Between Microinfarcts and Blood Pressure Trajectories (2017) (9)
- PRKAR1B mutations are a rare cause of FUS negative neuronal intermediate filament inclusion disease. (2015) (8)
- TDP‐43 in the olfactory bulb in Alzheimer's disease (2016) (8)
- Neuroimaging Correlates of Pathologically-Defined Atypical Alzheimer's Disease (P05.049) (2012) (8)
- Clinical features of autopsy-confirmed multiple system atrophy in the Mayo Clinic Florida brain bank. (2021) (8)
- Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme (2009) (8)
- Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures (2020) (8)
- Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes (2020) (8)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- Reply: LATE to the PART-y. (2019) (8)
- Aprosencephaly: Review of the literature and report of a case with cerebellar hypoplasia, pigmented epithelial cyst and Rathke's cleft cyst (2004) (8)
- Amyloid, PHF‐tau, Ubiquitin and Synaptic Markers in the Progression of Alzheimer's Disease: Immunochemical Analyses of Frontal Cortex from Prospectively Studied Elderly Humans (2002) (8)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (8)
- Introduction to Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (2011) (8)
- Fungal Infections of the Central Nervous System: Clinical, Radiographic and Laboratory Manifestations (2017) (8)
- Alzheimer’s Disease and Age-Related Pathology in Diffuse Lewy Body Disease (1992) (8)
- Mössbauer Studies of Pathological Brain Tissues Affected by PSP Disease (2009) (8)
- P1-140 Neuropathological outcome of mild cognitive impairment following progression to clinical dementia (2004) (8)
- Progranulin Mutations in Primary Progressive Aphasia (2016) (7)
- Tau Protein Expression in Adult Bovine Oligodendrocytes: Functional and Pathological Significance (2003) (7)
- Sarcolemmal defect and subsarcolemmal lesion in a patient withγ-sarcoglycan deficiency (1998) (7)
- Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis. (2016) (7)
- Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study (2012) (7)
- Chapter 3 – Neuropathology of Parkinson's Disease1 (2008) (7)
- Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus. (2011) (7)
- Senile cerebral amyloidosis (pathological aging) and cognitive status predictions: A neuropathology perspective (1996) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy (2021) (7)
- Globular Glial Tauopathy May be Mistaken for Corticobasal Syndrome—Pointers for the Clinician (2018) (7)
- Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus (2012) (7)
- Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19 (2021) (7)
- Neurofilament inclusion body disease (2003) (7)
- Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease (2019) (7)
- Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles (1987) (7)
- Concurrent variably protease-sensitive prionopathy and amyotrophic lateral sclerosis (2014) (7)
- Cytomembranous inclusions in the brain of a patient with the acquired immunodeficiency syndrome (2004) (7)
- Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures. (2019) (7)
- Clinical, pathological and genetic characteristics of Perry disease—new cases and literature review (2021) (7)
- Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains (2016) (7)
- V37 Common variants affect risk for the tauopathy progressive supranuclear palsy (2011) (7)
- Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion (2013) (7)
- Neuropathology and emerging biomarkers in corticobasal syndrome (2022) (7)
- SUBACOTE AIDS ENCEPHALITIS: IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED CELLS BY AN IMPROVED DOUBLE-IMMUNOSTAINING METHOD (1989) (6)
- Cerebrovascular pathology and misdiagnosis of multiple system atrophy: An autopsy study. (2020) (6)
- Interpretable deep learning of myelin histopathology in age-related cognitive impairment (2022) (6)
- Changes in the expression of genes associated with intraneuronal amyloid-beta and tau in Alzheimer's disease. (2010) (6)
- A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study. (2014) (6)
- A 66KD HEAT-STABLE NEURONAL PROTEIN REACTS WITH AN ANTISERUM TO THE BETA-AMYLOID PRECURSOR PROTEIN: 155 (1989) (6)
- Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy (2020) (6)
- Disproportionately enlarged subarachnoid-space hydrocephalus (DESH) in normal pressure hydrocephalus misinterpreted as atrophy: autopsy and radiological evidence (2019) (6)
- The Launch of International Journal of Clinical and Experimental Pathology (2008) (6)
- BASAL GANGLIA NEUROPIL THREADS IN PROGRESSIVE SUPRANUCLEAR PALSY: 71 (1989) (6)
- ANTIBODIES TO NON-AMYLOID COMPONENT OF PLAQUES (NACP) SPECIFICALLY LABEL LEWY BODIES AND LEWY NEURITES, BUT NOT OTHER INCLUSIONS IN NEURODEGENERATIVE DISEASES (1998) (6)
- Regional patterns of atrophy on MRI in Alzheimer’s disease: Neuropsychological features and progression rates in the ADNI cohort (2013) (6)
- Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) (6)
- Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. (2016) (6)
- Old age genetically confirmed frontotemporal lobar degeneration with TDP‐43 has limbic predominant TDP‐43 deposition (2021) (6)
- Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease (2022) (6)
- December 14, 2009Plenary Session December 14Not your father's Parkinson's disease: non-motor symptoms of PD8:00–10:00 Hall IO.014 Neuropathology of non-motor features of Parkinson disease (2009) (6)
- MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease (2021) (6)
- Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases. (2020) (6)
- Association study between multiple system atrophy and TREM2 p.R47H (2018) (6)
- Dopamine beta-hydroxylase deficiency involves the central autonomic network. (2006) (5)
- The presenilin 1 p.Gly206Ala mutation is a frequent cause of early-onset Alzheimer's disease in Hispanics in Florida. (2016) (5)
- Diagnostic Accuracy of Amyloid and FDG PET in Pathologically-Confirmed Dementia (S8.005) (2014) (5)
- O1-01-02: Alzheimer's disease with relative hippocampal sparing: A distinct clinicopathologic variant (2008) (5)
- Common variation at the LRRK2 locus is associated with survival in the primary tauopathy progressive supranuclear palsy (2020) (5)
- Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP. (2000) (5)
- Non-Amnestic Mild Cognitive Impairment Progresses to Dementia with Lewy Bodies (S24.002) (2013) (5)
- Multiple System Atrophy: Clinical, Genetics, and Neuropathology (2017) (5)
- Concurrent neurodegenerative pathologies in periventricular nodular heterotopia (2015) (5)
- Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain (2022) (5)
- Authors' Response. (2021) (5)
- NEUROPSYCHOLOGICAL CHARACTERISTICS OF SUBJECTS WITH AND WITHOUT CORTICAL ALZ50 IMMUNOREACTIVITY (1989) (5)
- Ultrastructure of ubiquitin‐positive, TDP‐43‐negative neuronal inclusions in cerebral cortex of C9ORF72‐linked frontotemporal lobar degeneration/amyotrophic lateral sclerosis (2012) (5)
- Aberrant accumulation of ErbB4 in progressive supranuclear palsy (2018) (5)
- Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI (2022) (5)
- Hippocampal-sparing Alzheimer's disease presenting as corticobasal syndrome. (2012) (5)
- Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging‐pathology study (2020) (5)
- Brainstem atrophy on routine MR study in pallidopontonigral degeneration (2009) (5)
- LATE-NC staging in routine neuropathologic diagnosis: an update (2022) (5)
- Clinical and pathological characteristics of later onset multiple system atrophy (2022) (5)
- MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features (2020) (5)
- Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy (2022) (5)
- Characterization of frontotemporal dementia +/- amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (5)
- The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia (2020) (5)
- Genetics of Vascular Dementia. (2010) (5)
- Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits (2021) (5)
- Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures (2021) (5)
- Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease (2021) (5)
- Clinical presentation of a patient with SLC20A2 and THAP1 deletions: differential diagnosis of oromandibular dystonia. (2015) (5)
- TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease (2020) (5)
- Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions (2021) (5)
- An MRI‐Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease (2016) (5)
- Neuropathology of progressive supranuclear palsy after treatment with tilavonemab (2021) (5)
- Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2018) (5)
- Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders (2022) (5)
- Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies (2021) (5)
- TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration (2021) (5)
- Central Nervous System Pathology in Children with AIDS and Focal Neurologic Signs — Stroke and Lymphoma (1990) (5)
- X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia. (2019) (5)
- Limbic lobe microvacuolation is minimal in Alzheimer's disease in the absence of concurrent Lewy body disease. (2008) (5)
- A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy (2011) (5)
- LRP10 variants in progressive supranuclear palsy (2020) (5)
- α‐synuclein astrogliopathy: A possible specific feature in α‐synucleinopathy (2017) (5)
- Monoclonal Antibodies Show Cross-Reactivity of Alzheimer Neurofibrillary Tangles and Heat-Stable Microtubule-Associated Proteins (1987) (5)
- Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear Palsy (2020) (4)
- PONTINE CYTOSKELETAL PATHOLOGY IN THE DIFFERENTIAL DIAGNOSIS OF NON-ALZHEIMER DEMENTIAS (1997) (4)
- Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis (2012) (4)
- Diffuse Lewy body disease presenting as Parkinson's disease with progressive aphasia (2022) (4)
- Neuropathological Findings of CSF1R‐Related Leukoencephalopathy After Long‐Term Immunosuppressive Therapy (2022) (4)
- C 9 orf 72 BAC Transgenic M ice Display Typical Pathologic Features of ALS / FTD Highlights (2015) (4)
- Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology (2021) (4)
- Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal (2021) (4)
- Pathology‐Proven Corticobasal Degeneration Presenting as Richardson's Syndrome (2020) (4)
- DCTN1 mutations in families with parkinsonism, depression, weight loss and central hypoventilation: Perry syndrome (2008) (4)
- TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD (2018) (4)
- Patterns of etiology and antibiotic resistance of bacteria causing urinary tract infections in the Anhui Provincial Hospital (2016) (4)
- American Society for Stereotactic and Functional Neurosurgery Bestows Distinguished Service Award on Dr. med. h.c. mult. Thomas Karger and Prof. Dr. Phil Gildenberg (2003) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Early Onset Alzheimer ’ s Disease with Spastic Paraparesis , Dysarthria and Seizures and N 135 S Mutation in PSEN 1 (2009) (4)
- AD-linked R47H-TREM2 mutation induces disease-enhancing proinflammatory microglial states in mice and humans (2020) (4)
- International Medical Workshop covering progressive supranuclear palsy, multiple system atrophy and cortico basal degeneration (2001) (4)
- Temporal order of clinical and biomarker changes in familial frontotemporal dementia (2022) (4)
- ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion (2022) (4)
- Intraneuronal amyloid-β accumulation in basal forebrain cholinergic neurons: a marker of vulnerability, yet inversely related to neurodegeneration. (2015) (4)
- Clinical and pathologic features of cognitive-predominant corticobasal degeneration (2020) (4)
- TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death (2021) (4)
- Progranulin is located in secretory granules and vesicles of neutrophils and macrophages by immunogold electron microscopy: 41.7 (2007) (4)
- Autopsy Validation of Progressive Supranuclear Palsy‐Predominant Speech/Language Disorder Criteria (2021) (4)
- Neuropathology and pathogenesis of dementia with lewy bodies (2005) (4)
- Genetic risk factors for posterior cortical atrophy (2015) (3)
- Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy. (2022) (3)
- [Magnetic resonance imaging with 21.1 T and pathological correlations--diffuse Lewy body disease]. (2011) (3)
- Errata (2010) (3)
- Latent trait modeling of tau neuropathology in progressive supranuclear palsy (2021) (3)
- Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes (2021) (3)
- Microglia and macrophages in HIV-related CNS neuropathology (1992) (3)
- Frequency and Relation of Argyrophilic Grain Disease and Thorn-Shaped Astrocytes in Alzheimer’s Disease (2008) (3)
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease (2013) (3)
- Enhanced binding of advanced glycation endproducts (age) by apo e4 isotype linkt mechanisms of plaque deposition in alzheimer's disease (1996) (3)
- TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration (2022) (3)
- Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins (2022) (3)
- Mismatch between plaques and tangles in staging Alzheimer pathology (1995) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- EXPRESSION OF HLA-DR AND Fc RECEPTOR III IN AIDS ENCEPHALITIS: 195 (1990) (3)
- Role of molecular polymorphism in defining tau filament structures in neurodegenerative diseases (2021) (3)
- Enrichment of Phosphorylated Tau (Thr181) and Functionally Interacting Molecules in Chronic Traumatic Encephalopathy Brain-derived Extracellular Vesicles (2021) (3)
- Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein (2020) (3)
- Reply re: “Profile of cognitive impairment and underlying pathology in multiple system atrophy” (2017) (3)
- A neuronal antigen in the brains of Alzheimer patients (1987) (3)
- Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia (2022) (3)
- Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations (2021) (3)
- Chapter 3 Structural Changes in the Aged Brain (1997) (3)
- Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes. (2021) (3)
- Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5 (2020) (3)
- DCTN1 variation in pathologically-confirmed PSP and CBD tauopathy. (2017) (3)
- Amino acid residues 226-240 of tau, which encompass the first Lys-Ser-Pro site of tau, are partially phosphorylated in Alzheimer paired helical filament-tau. (1994) (3)
- Neuropathology and staging of parkinson’s disease (2007) (3)
- Review Article Neuropathology of non-Alzheimer degenerative disorders (2010) (3)
- Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy (2022) (3)
- EVIDENCE THAT MICROGLIA IN THE HUMAN BRAIN MAY BE DERIVED FROM NEUROECTODERM: 124 (1989) (3)
- A Clinicopathological Study of Rest Tremors in the Elderly (2004) (2)
- Preliminary Results of the NINDS/NIBIB Consensus Meeting to Evaluate Pathological Criteria for the Diagnosis of CTE (P2.178) (2015) (2)
- P3-068 Myo-inositol/creatine ratio correlates with the neuropathological involvement in Alzheimer's disease (2004) (2)
- Correction to: Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) (2)
- MORPHOLOGIC DIFFERENTIATION OF HUMAN FETAL MICROGLIA IN CULTURE INDUCED BY ASTROCYTES, LIPOPOLYSACCIIARIDE, OR COLONY STIMULATING FACTORS (1993) (2)
- P3-343 Progressive supranuclear palsy presenting as progressive nonfluent aphasia (2004) (2)
- The Neuropathology of Patients with Dementia and Non-Dementia in the Oldest-old (P2.176) (2015) (2)
- Brain tau deposition linked to systemic causes of death in normal elderly (2017) (2)
- GCH1 expression in human cerebellum from healthy individuals is not gender dependant (2009) (2)
- Antemortem hippocampal atrophy predicts presence of Alzheimer's disease pathology in pathologically proven lewy body disease (2011) (2)
- Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology (2022) (2)
- Neuropathology of McLeod Syndrome (2021) (2)
- TG-1: a marker for neuronal nuclei in Alzheimer's disease (1994) (2)
- Gerstmann-Sträussler-Scheinker syndrome misdiagnosed as conversion disorder (2019) (2)
- Neurocognitive speed associates with frontotemporal lobar degeneration TDP-43 subtypes (2013) (2)
- Alzheimer - Parkinson Disease Spectrum and Diffuse Lewy Body Disease (1990) (2)
- Sarcolemmal defect and subsarcolemmal lesion in a patient with gamma-sarcoglycan deficiency. (1998) (2)
- Isolated central nervous system granulomatosis resembling sarcoidosis (1989) (2)
- AMYLOID BURDEN DETERMINED BY IMAGE ANALYSIS CORRELATES WITH CONVENTIONAL HISTOCHEMICAL METHODS AND CLINICAL MEASURES OF COGNITIVE DECLINE (1997) (2)
- MRI in pathologically defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease (2012) (2)
- Progressive Supranuclear Palsy and Corticobasal Degeneration. (2021) (2)
- Absence of C 9 ORF 72 expanded or intermediate repeats in autopsy confirmed Parkinson Disease (2014) (2)
- Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1. (2019) (2)
- LRRK2 knockout mice display alterations in emotional and motor co-ordination behaviours (2012) (2)
- GRN Mutations Are Associated with Lewy Body Dementia (2022) (2)
- MRI in pathologically-defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease (2012) (2)
- Clinical, Imaging, and Pathologic Characteristics of Patients With Right vs Left Hemisphere–Predominant Logopenic Progressive Aphasia (2021) (2)
- Chapter 7 Ubiquitinopathies (2007) (2)
- Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis (2012) (2)
- AIDS (1985) (2)
- Investigating ELOVL7 coding variants in multiple system atrophy (2021) (2)
- HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS (2022) (2)
- Microbeam FT-IR Spectroscopic Examination of Diseased Brain Tissues (1997) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- Asymmetrical Primary Lateral Sclerosis Presenting as Corticobasal Syndrome. (2022) (2)
- Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins (2022) (2)
- CENTRAL NERVOUS SYSTEM IN CHILDREN WITH AIDS – A MULTICENTER STUDY: 268 (1990) (2)
- Familial frontotemporal dementia with a novel tau exon-10 splice site mutation: Nature confirms a theoretic construct (2000) (2)
- COMPARISON OF NEUROFIBRILLARY LESIONS IN PROGRESSIVE SUPRANUCLEAR PALSY, PICKʼS DISEASE, AND CORTICOBASAL DEGENERATION: 146 (1995) (2)
- Borreliosis and Alzhelmer's disease (1987) (2)
- Cerebral Microvascular Erdheim-Chester Disease: A Perivascular Hematopoietic Vasculopathy (2021) (2)
- Phosphorylated tau fluid biomarker sites recognize earlier neurofibrillary tangle maturity levels in the postmortem Alzheimer’s disease brain (2021) (2)
- Clinicopathologic Correlations in 172 Cases of REM Sleep Behavior Disorder ± a Coexisting Neurologic Disorder (PL01.003) (2013) (2)
- Differentiating clinicopathologic and genetic aspects of hippocampal sclerosis in Alzheimer's disease from limbic predominant Alzheimer's disease and “pure” hippocampal sclerosis (2012) (2)
- [11C]PBB3 PET VISUALIZES TAU AGGREGATES IN PATIENTS WITH FTDP-17 MAPT GENE MUTATION (2016) (2)
- Risk Factors for Dementia with Lewy Bodies (S24.005) (2012) (2)
- Neuropathology of Diffuse Lewy Body Disease: 128 (1987) (2)
- ETIOLOGY OF AUTISTIC BEHAVIOR: CLUES FROM TWO CASES WITH AN UNUSUAL VARIANT OF NEUROAXONAL DYSTROPHY (1999) (2)
- Erratum: Correction to: Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (Acta neuropathologica communications (2020) 8 1 (72)) (2020) (2)
- Evidence of cerebellar TDP-43 loss of function in FTLD-TDP (2022) (2)
- Neuronal intermediate filament inclusion disease may be incorrectly classified as a subtype of FTLD-FUS. (2020) (2)
- Nanoparticles With Affinity for α-Synuclein Sequester α-Synuclein to Form Toxic Aggregates in Neurons With Endolysosomal Impairment (2021) (2)
- Differential diagnosis of neurodegenerative dementias using structural MRI (2009) (2)
- THAL AMYLOID PHASE: CLINICOPATHOLOGIC AND PIB-PET IMPLICATIONS OF AD PATHOPHYSIOLOGY (2014) (2)
- MONOCLONAL ANTIBODIES DEMONSTRATE A COMMON ANTIGENIC DETERMINANT BETWEEN ALZHEIMER NEUROFIBRILLAR TANGLES AND NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSI (1985) (1)
- LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors (2012) (1)
- Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant (2022) (1)
- P4-118 MRI correlates of the language and behavioral variants of frontotemporal dementia when both are characterized by ubiquitin-only immunoreactive changes (2006) (1)
- Sporadic diffuse leucoencephalopathy with axonal spheroids: report of a profuse and rapid cortical–spinal degeneration (2012) (1)
- Capgras syndrome in dementia with Lewy bodies: a possible association of severe cortical Lewy body pathology. (2021) (1)
- P2.187 Relationship of neighboring tissue and gliosis to a-synuclein pathology in a fetal graft to treat Parkinson disease (2009) (1)
- Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants (2018) (1)
- Relationships between lewy and tau pathologies in 375 consecutive non‐Alzheimer's olfactory bulbs (2018) (1)
- Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus (2015) (1)
- Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) (2019) (1)
- Association of Mitochondrial DNA Genomic Variation With Risk of Pick Disease (2021) (1)
- Neuroanatomical Signature of C9ORF72: A Comparison to MAPT, Progranulin and Sporadic FTD (P05.061) (2012) (1)
- eSNPs within VAMP1 show genetic association with late onset Alzheimer's disease (2010) (1)
- LRRK2 (Leucine-Rich Repeat Kinase 2) Gene on PARK8 Locus in Families with Parkinsonism (2008) (1)
- Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy (2021) (1)
- ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease (2014) (1)
- Neuropathological characterization of progranulin-deficient mice: Accelerated lipofuscin accumulation suggests a role for progranulin in successful aging (2009) (1)
- Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels (2014) (1)
- Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels (2022) (1)
- Normal cognition in transgenic BRI2-Aβ mice (2013) (1)
- Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility (2015) (1)
- TDP-43 AMPLIFIES MEMORY LOSS AND HIPPOCAMPAL ATROPHY IN ALZHEIMER'S DISEASE (2014) (1)
- AMYLOID ANGIOPATHY IN DIFFUSE LEWY BODY DISEASE: 47 (1990) (1)
- Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration (2022) (1)
- Amyloid fibrils in frontotemporal lobar degeneration with TDP-43 inclusions are composed of TMEM106B, rather than TDP-43 (2022) (1)
- TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease. (2022) (1)
- Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. (2022) (1)
- Neuropathology of Parkinson’s disease after focused ultrasound thalamotomy (2022) (1)
- Assessing the effect of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism on mRNA transcript levels, Alzheimer’s disease (AD) risk and cognitive performance (P2.163) (2015) (1)
- GENETIC MUTATIONS IN MAPT AND SIGNIFICANT VARIABILITY IN TAU PROTEIN MODIFICATIONS INDICATE THE EXISTANCE OF A WIDE ARRAY OF STRAINS WITHIN AND ACROSS PRIMARY AND SECONDARY TAUOPATHIES (2017) (1)
- Single Nuclei Transcriptome Reveals Perturbed Brain Vascular Molecules in Alzheimer’s Disease (2021) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- Quantitative characterization of brain β-amyloid using a joint PiB/FDG PET image histogram (2014) (1)
- Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech (2023) (1)
- ALZHEIMER’S DISEASE MAY NOT BE MORE COMMON IN WOMEN; MEN MAY BE MORE COMMONLY MISDIAGNOSED (2016) (1)
- Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old (2022) (1)
- Inducible expression of wild-type TDP-43 is toxic to mouse hippocampal and cortical neurons (2010) (1)
- Association of a missense cathepsin D (CTSD) SNP with risk of Alzheimer's disease (2009) (1)
- Neuropathology of Parkinsonism (2013) (1)
- P4-152: Sex differences in perivascular tauopathy in the mediobasal tuberal hypothalamus in neurodegenerative diseases in humans (2008) (1)
- ALZHEIMER CHANGES IN DIFFUSE LEWY BODY DISEASE (LBD): 237 (1989) (1)
- Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy (2020) (1)
- Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias (2014) (1)
- The 5th International Conference on Molecular Neurodegeneration: Overlapping Pathologies and Common Mechanisms (2019) (1)
- Orthostatic hypotension preceding dementia with Lewy bodies by over 15 years: a clinicopathologic case report (2020) (1)
- Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease (2022) (1)
- Conserved Architecture of Brain Transcriptome Changes between Alzheimer’s Disease and Progressive Supranuclear Palsy in Pathologically Affected and Unaffected Regions (2021) (1)
- Focal Cortical Patterns in Hippocampal Sparing AD Reveal Significant Clinical Differences (S48.001) (2014) (1)
- Literature Review of Genetic Disorders with tau Pathology (I12.004) (2016) (1)
- Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility (2015) (1)
- NEUROPATHOLOGIC FEATURES OF AV1451 TAU PET AUTORADIOGRAPHY IN DEMENTIA (2016) (1)
- WIDESPREAD REDUCTION OF SCMATOSTATIN‐LIKE IMMUNOREACTIVITY IN NON‐PICK LOBAR ATROPHY: 129 (1987) (1)
- Dementia with Lewy Bodies: Pathological Basis of the Cingulate Island Sign (P6.332) (2014) (1)
- The Role of Microglia and Astrocytes in Amyloid Deposition in Alzheimer's Disease (1995) (1)
- Association of mitochondrial genomic background with risk of Multiple System Atrophy. (2020) (1)
- Tau kinases and Parkinson's disease: Guilt by association? (2005) (1)
- The relationship of primary age-related tauopathy (PART) to snap: Controversy or parallel? (2015) (1)
- Dual pathologies: Utility of TAR DNA‐binding Protein 43 (TDP‐43) Staining in Patients with Frontal and Temporal Lobe Abnormalities and Alzheimer disease (2007) (1)
- Pattern Of Brain Atrophy Rates On Serial MRI In Autopsy-Confirmed Dementia With Lewy Bodies (S48.004) (2014) (1)
- Hematologic Emergencies in the Postoperative Neurointensive Care Unit Setting: Illustrative Case Series and Differential Diagnosis. (2021) (1)
- Transthyretin as Potential Biomarker for C9ORF72-related Diseases (I8-2A) (2015) (1)
- Ultrastructural Pathology of Neurofibrillary Tangles in Transgenic Mice Carrying Mutant (P301l) Human Tau Gene (2000) (1)
- Atypical Progressive Supranuclear Palsy Manifesting as Pure Akinesia with Gait Freezing: A Pathologically Proven Case (P04.155) (2013) (1)
- Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy (2022) (1)
- Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model (2014) (1)
- Launch of american journal of neurodegenerative disease. (2012) (1)
- Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease (2018) (1)
- Corrigendum to “Genome-wide association interaction analysis for Alzheimer's disease.” [Neurobiol. Aging 35 (2014) 2436–2443] (2016) (1)
- Apoptotic Neuron-Derived Histone Amyloid Fibrils Induce α-Synuclein Aggregation (2020) (1)
- A Tribute to a Neuropathologist, Robert D. Terry (2005) (1)
- Subject Index Vol. 17, 2004 (2004) (1)
- Globular Glial Tauopathy Presenting as Semantic Variant PPA (P6.226) (2016) (1)
- P3.059 Glial activation in incidental Lewy body disease (2009) (1)
- Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant (2019) (1)
- Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration (2019) (1)
- MODIFIED BIELSCHOWSKY AND IMMUNOHISTOCHEMICAL STUDIES ON CEREBELLAR PLAQUES IN ALZHEIMERʼS DISEASE (AD): 107 (1989) (1)
- Original Article Perivascular Neuritic Dystrophy Associated with Cerebral Amyloid Angiopathy in Alzheimer's Disease (2008) (1)
- Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study (2013) (1)
- Genetic association of variants with late-onset Alzheimer's disease risk and brain gene expression (2012) (1)
- Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts. (2021) (1)
- A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (1)
- In dementia with Lewy bodies, rapid eye movement sleep behavior disorder is associated with reduced Alzheimer's disease pathology and hippocampal atrophy (2012) (1)
- Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study (2013) (1)
- Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1 (2018) (1)
- Progranulin is located in secretory granules and vesicles of neutrophils and macrophages by immunogold electron microscopy (2007) (1)
- Detection of TDP‐43 in Alzheimer's disease and hippocampal sclerosis (2007) (1)
- A novel CSF1R variant in a South Dakota family with CSF1R-related leukoencephalopathy. (2022) (1)
- Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates (2017) (1)
- LRRK2-Associated Parkinsonism (2007) (0)
- IC-03-07: A voxel-based morphometry study correlating MRI with Braak neurofibrillary tangle stage at autopsy (2008) (0)
- The neuropathological diagnosis of Alzheimer’s disease (2019) (0)
- Frequency of TAR DNA‐binding protein 43 (TDP‐43) increases linearly with age in the demented and non‐demented elderly population (2022) (0)
- 200 Gliomatosis Cerebri Presenting with Hydrocephalus and Dementia (2013) (0)
- Oral Sessions: O3-04: Genetics: Transcriptomic and Epigenetic Changes in Alzheimer’s Disease and Related Traits (2014) (0)
- Replication of LOAD GWAS Associations (2011) (0)
- Isolated Jaw and Tongue Tremor in a Definite Case of Progressive Supranuclear Palsy (2022) (0)
- Influence on phenotype of the postnatal developmental period in mice expressing human M337V TDP-43 (2012) (0)
- Neurodegenerative Diseases: Neuropathology of Parkinson's disease (2005) (0)
- C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation (2019) (0)
- Coronin-1a: a novel microglial marker for use in paraffin embedded tissue: 41.1 (2007) (0)
- Smad Ubiquitination Regulatory Factor-2 and Phosphorylated Smad2/3 Immunoreactivity in Pick's Disease (P04.153) (2013) (0)
- the Environment Reaching the Limits of Genome-wide Significance in Alzheimer Disease : Back to (2010) (0)
- Tau Negative FTLD Without Abnormal TDP‐43 Immunoreactivity (2008) (0)
- Neurotoxicity society (2009) (0)
- Concordant association of functional IDE variant with IDE mRNA, Aß, and Alzheimer's disease (2009) (0)
- USING TISSUE-BASED TRANSCRIPTOMICS TO PROFILE CELL TYPE VARIABILITY IN THE BRAIN (2017) (0)
- Clinical Deep Phenotyping of ABCA7 Mutation Carriers (2022) (0)
- Long‐read sequencing and complete telomere to telomere human reference genome provide deeper insight into human brain transcriptomics (2022) (0)
- Corrigendum: Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes. (2018) (0)
- A COMPARATIVE ANALYSIS OF SPINAL CORD PATHOLOGY IN 4 R-TAUOPATHIES : PPND , PSP AND CBD (2011) (0)
- IDENTIFICATION OF POLYPEPTIDES CONTAINING THE ANTIGENIC DETERMINANTS) IN COMMON WITH ALZHEIMERʼS NEUROFIBRILLARY TANGLE (1985) (0)
- AN ANTIBODY TO A SYNTHETIC PEPTIDE WITH AN AMINO ACID SEQUENCE IDENTICAL TO AN AMINO-TERMINAL REGION OF PRESENILIN-1 IMMUNOSTAINS NEUROFIBRILLARY TANGLES IN ALZHEIMERʼS DISEASE (AD) (1996) (0)
- A Unique Case of Cortical Myoclonus Sensitive to Visual Stimuli in the Peripersonal Space (2009) (0)
- Alzheimer's disease from a pathological point of view and what neurologists can learn from it (2011) (0)
- Triplication of Alpha-Synuclein is Causal of Neuropathologically Confirmed Parkinson ’ s Disease , Diffuse Lewy Body Disease , and Multiple System Atrophy in a Single Kindred (2003) (0)
- COGNITION IN PATIENTS WITH ALZHEIMER’S DISEASE (2014) (0)
- P4-38 Increased Deposition of Fibronectin (FN) in the Vascular Basal Lamina (VBL) of Brains with Degenerative Diseases (2002) (0)
- TDP‐43 Neuronal Cytoplasmic Inclusions in the Amygdala of Patients with Advanced Alzheimer Disease (2008) (0)
- Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures (2020) (0)
- Neurofibrillary tangles, neuronal loss, and severe motor changes develop in transgenic mice expressing tau (4R0N) with the frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) mutation P301L (2000) (0)
- Progress in PSP and CBD (2002) (0)
- Paired Helical Filaments in Corticobasal Degeneration (2007) (0)
- Genetic and epigenetic influences on brain gene expression in psp (2015) (0)
- Conserved architecture of brain transcriptome changes between Alzheimer's disease and progressive supranuclear palsy in pathologically affected and unaffected regions (2021) (0)
- Vascular Pathology Is Associated with Rate of Cognitive Decline Independent of AD Pathology (Einstein Aging Study) (P6.222) (2016) (0)
- Presence of Microinfarcts at Autopsy is Associated with Increased Rate of Gray Matter Atrophy on Antemortem MRI (P4.017) (2014) (0)
- Monoclonal A ntibodies to A lzheimer Neurofibrillary Tangles 2. Demonstration of a Common Antigenic Determinant Between ANT and Neurofibrillary Degeneration in Progressive Supranuclear Palsy (2007) (0)
- Erratum: Identificaon of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles (Journal of Neuropathology and Experimental Neurology (2006) 65, (1157-1169)) (2007) (0)
- OP-BRAI180237 2895..2907 (2018) (0)
- PATHOLOGIC ASSOCIATIONS OF FDG PET IN LEWY BODY DISEASE (2019) (0)
- P3-431 Ubiquitin-binding protein p62 is present in tau-positive, ubiquitin-negative glial inclusions in 3R and 4R tauopathies (2006) (0)
- CLINICAL CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH EVENTUAL LEWY BODY DISEASE PATHOLOGY (2019) (0)
- MULTIPLE ABCA7 MISSENSE VARIANTS MINED FROM THE EXOME VARIANT SERVER SHOW INDEPENDENT ASSOCIATION WITH INCREASED OR DECREASED RISK OF LATE-ONSET ALZHEIMER'S DISEASE (LOAD) (2014) (0)
- Mixed Alzheimer's and Lewy Body Disease Pathology Patterns (2010) (0)
- Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease (2021) (0)
- Effect of APOE ɛ4 genotype on age at onset and comorbid pathologies in multiple system atrophy (P8-11.004) (2023) (0)
- P3-190 Lewy Body (LB) pathology and clinical diagnoses in the National Alzheimer’s Coordinating Center (NACC) database (2006) (0)
- Cell type‐specific gene expression changes in Alzheimer’s patients with varying levels of cerebral amyloid angiopathy (2021) (0)
- Original Article C9ORF72 repeat expansions and other FTD gene muta- tions in a clinical AD patient series from Mayo Clinic (2012) (0)
- Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease (2018) (0)
- Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains (2020) (0)
- 2.321 Do chronic non-specific brain insults predispose to incidental Lewy Body Disease? An exploratory study (2007) (0)
- Dissecting the Neuropathological Contributors to Rapidly Progressive Dementia (2022) (0)
- Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant (2019) (0)
- Brain regional distribution of apolipoprotein E and beta-amyloid peptides in cognitively normal persons (2012) (0)
- Late‐onset mania in autopsy‐confirmed Lewy body disease: A rare symptom of prodromal dementia with Lewy bodies? (2022) (0)
- TRANSCRIPTIONAL REGULATION AT THE TREM GENE CLUSTER IN AD BRAINS (2014) (0)
- Comprar Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd Edition | Dennis Dickson | 9781405196932 | Blackwell Publishing (2011) (0)
- COGNITION AND HIPPOCAMPAL PATHOLOGIC DENSITY OF α-SYNUCLEIN, TAU AND AMYLOID-β IN DEMENTIA WITH LEWY BODIES (2017) (0)
- Genome-Wide Association Study of Brain Gene Expression Levels (eGWAS) (2011) (0)
- Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer’s Disease (2023) (0)
- Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
- P3-294 The impact of chip on neurodegenerative diseases (2006) (0)
- Transcript Profiling Analysis Of Alzheimer’s Disease Brains. (I5-1.003) (2014) (0)
- In dementia with Lewy bodies RBD is associated with reduced Alzheimer's disease pathology and hippocampal atrophy (2012) (0)
- Perry syndrome – the genetic, clinical, and pathological characteristics of the disease (P8-11.001) (2023) (0)
- ＜Symposium IV＞Genetic variation in PCDH11X is associated with susceptibility to late onset Alzheimer's disease (2010) (0)
- Doublet Tau Fibril from Corticobasal Degeneration Human Brain Tissue (2020) (0)
- P2-172: Wild-type mouse tau transgenic model: Halfway to a complete AD model (2008) (0)
- Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity (2018) (0)
- PATHOLOGIC INVESTIGATION OF MICROINFARCTS AND ASSOCIATION WITH GRAY MATTER ATROPHY ON ANTEMORTEM MRI (2014) (0)
- Understanding the transcriptional (dys)regulation in progressive supranuclear palsy (2021) (0)
- Neuropathology of Dementia in Parkinson's Disease (2011) (0)
- PATHOGENESIS OF CORTICOSPINAL TRACT DEGENERATION IN PEDIATRIC AIDS: 251 (1989) (0)
- Characterization of brain region- and disease-specific IDE expression in Alzheimer patients and controls (2010) (0)
- Gene expression analysis of TDP-43 transgenic mice (2010) (0)
- P4-120 Demystifying the degenerative aphasias and apraxia of speech (2006) (0)
- HISTORY OF HEAD INJURY AND ALZHEIMER'S DISEASE (AD) NEUROPATHOLOGY (2014) (0)
- Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol (2020) (0)
- Effect of strain background on pathology progression in tau mouse model (2011) (0)
- P3.026 Clinico-pathologic comparison of Perry syndrome and distal spinal and bulbar muscular atrophy (2009) (0)
- Accumulation of amyloid β protein in the detergent-insoluble membrane compartment (2000) (0)
- Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer’s disease? (2014) (0)
- CORTICAL MICROINFARCTS AND REGIONAL GRAY MATTER LOSS ON ANTEMORTEM MRI (2016) (0)
- MAPPING FUNCTIONAL REGULATORY VARIANTS AT ALZHEIMER’S DISEASE RISK LOCI (2018) (0)
- Observational Study for MRI Characteristics in HDLS with a Known Gene Mutation on Chromosome 5 (P06.180) (2012) (0)
- FDG-PET in Pathologically Confirmed 4R-Tauopathy Variants (P5.251) (2014) (0)
- American Association of Neuropathologists, Inc. Abstracts of the 84th Annual Meeting: April 4-7, 2008 San Diego, California (2008) (0)
- Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci (2018) (0)
- Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients (2018) (0)
- Apoptotic Neuron-Derived Histone Amyloid Fibrils Induce α-Synuclein Aggregation (2020) (0)
- P2-090 ABETA42 is required for amyloid deposition in transgenic mice (2004) (0)
- Visualization of tau lesions in brains of tauopathy patients and model mice using tau ligand PBB3 (2014) (0)
- Characterizing Amyloid Responsive Microglia in a Cognitively Resilient Patient with Alzheimer’s Disease Neuropathologic Change: A Case Report (2022) (0)
- PL-02-03: The neuropathology of the non-Alzheimer's disease dementias (2008) (0)
- HIV ENCEPHALITIS PRESENTING AS A MASS LESION OF THE CNS (1997) (0)
- Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy (2019) (0)
- Progressive changes in amyloid, apolipoprotein-E, synaptic markers and ubiquitin in frontal lobe of prospectively studied elderly humans (2000) (0)
- P2-438 COGNITION AND HIPPOCAMPAL PATHOLOGIC DENSITYOF a-SYNUCLEIN, TAUANDAMYLOID-b IN DEMENTIAWITH LEWY BODIES (2017) (0)
- EXPERIMENTAL MODELS OF CRYPTOCOCCAL MENINGOENCEPHALITIS: CONTRIBUTION OF IMMUNE MOLECULES TO THE RESTRICTION OF CRYPTOCOCCAL PROLIFERATION AND PROPAGATION (1995) (0)
- Characterization of Frontotemporal Dementia +/- Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 (S54.005) (2012) (0)
- Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40 (2020) (0)
- Interleukin-1, microglia and reactive astrocytes (1995) (0)
- Investigation Of Transcriptional Regulation At The Alzheimer’s Disease Risk Loci. (S28.006) (2014) (0)
- CORTICAL MICROINFARCTS AND REGIONAL GRAY MATTER LOSS ON ANTEMORTEM MRI (2016) (0)
- Erratum (1979) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- IC-PL-02 Update on pathology of the dementias, and what should/could imagers be imaging (2006) (0)
- Novel Progressive Supranuclear Palsy (PSP) Risk Loci Variants Associate with Brain Gene Expression Levels (S54.002) (2012) (0)
- Deciphering cellular transcriptional alterations in Alzheimer’s disease brains (2020) (0)
- Granulocyte Colony Stimulating Factor causes cerebellar deficits and anxiety in a mouse model of CSF-1 receptor-related leukoencephalopathy (2022) (0)
- Intermediate Repeats Confer Risk for Corticobasal Degeneration and Increase C 9 orf 72 Expression (2020) (0)
- IDENTIFICATION OF T-LYMPHOCYTES IN ADULT AIDS PATIENTS WITH MIS WITHOUT SUBACUTE GIANT CELL ENCEPHALITIS: 188 (1990) (0)
- Clinical value of CSF tau, p‐tau181, neurogranin and neurofilaments in familial frontotemporal lobar degeneration (2021) (0)
- microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP) (2016) (0)
- P1-308: A voxel-based morphometry study correlating MRI with Braak neurofibrillary tangle stage at autopsy (2008) (0)
- Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood (2021) (0)
- Subventricular glial nodules in neurofibromatosis 1 with craniofacial dysmorphism and occipital meningoencephalocele (2019) (0)
- Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2018) (0)
- TDP-43 IN ATYPICAL ALZHEIMER’S DISEASE DEMENTIA (2018) (0)
- Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography (2015) (0)
- biomarkers DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and (2007) (0)
- 2.012 Perry's syndrome is a unique TDP-43 proteinopathy (2007) (0)
- An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016) (0)
- Progression of cognitive impairment is slower in leukoencephalopathy than in Alzheimer's disease: A clinicopathologic study (2000) (0)
- ABNORMAL CHROMOSOME COPY NUMBER AND ASSOCIATED NEURONAL CELL DEATH IN FRONTOTEMPORAL LOBAR DEGENERATION (2017) (0)
- Association of glyceraldehyde-3-phosphate dehydrogenase locus variant with late-onset Alzheimer's disease (2010) (0)
- Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4 (2021) (0)
- Clinical and neuropathological features of ALS/FTD with TIA1 mutations (2017) (0)
- Towards a comprehensive analysis of the role of inflammatory mediators on Alzheimer's like pathology in pre-clinical mouse models (2011) (0)
- Antemortem IL-6 levels associated with vascular pathology but not Alzheimer pathology in cases from the Einstein Aging Study (2009) (0)
- Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis: 41.2 (2007) (0)
- 1.012 Cardiac sympathetic denervation is early and progressive in Lewy body disease (2007) (0)
- Cancer survivors have a lower frequency of dementia in the 95+ oldest‐old (2021) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (0)
- Borreliosis and Alzheimer's disease. (1987) (0)
- Association Studies of Neuropathologically-Confirmed Cases and Controls Reveals that the PARK10 Locus is a Major Contributor to Sporadic Parkinson disease. (S7.005) (2015) (0)
- Diagnostic value of plasma P‐tau217 in frontotemporal dementia spectrum disorders (2021) (0)
- P2-029 Immunolabeling of tau and alpha-synuclein in the substantia nigra of rats injected with viral vectors carrying the mutant genes (2004) (0)
- Common GBA Variants in Parkinson's Disease and Lewy Body Dementia Patients (2020) (0)
- Letter to the editor, "Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease". (2020) (0)
- Clinicopathologic phenotypes of four cases with MAPT P301L mutation (P2.164) (2015) (0)
- AFRICAN AMERICAN BRAIN AUTOPSIES FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER (2016) (0)
- TAR DNA‐binding protein 43 (TDP‐43) contributes to the mismatch between medial temporal volumes and flortaucipir uptake in elderly patients with Alzheimer’s disease neuropathologic changes (2022) (0)
- American Journal of Neurodegenerative Disease: Editorial Board (2012) e-Century Publishing Corporation. (2012) (0)
- SELECTIVE VULNERABILITY OF THE CHOLINERGIC SYSTEM IN ALZHEIMER’S DISEASE SUBTYPES (2018) (0)
- Dementia with Lewy bodies: Frequency in a community-based autopsy series and accuracy of the clinical diagnostic criteria (2000) (0)
- Association of DNA methylation from the temporal cortex and cerebellum with AD‐related neuropathology and biochemistry (2022) (0)
- Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model (2022) (0)
- IC-02-05 GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN LONGITUDINAL BRAIN CHANGES AND BASELINE LEVELS OF CSFALZHEIMER’S DISEASE AND GLIAL BIOMARKERS IN HEALTHY ELDERS (2019) (0)
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2020) (0)
- TDP-43 in Alzheimer’s Disease Is Not Associated with Parkinsonian Features or Clinical FTD (P4.206) (2014) (0)
- Dual pathologies: utility of TAR DNA-binding protein 43 (TDP-43) staining in patients with frontal and temporal lobe abnormalities and Alzheimer disease: 41.3 (2007) (0)
- P1-102 Apoptosis of oligodendrocytes in an inducible model of tauopathy (2006) (0)
- Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies (2022) (0)
- Antemortem hippocampal atrophy on MRI predicts presence of Alzheimer's disease pathology in pathologically confirmed Lewy body disease (2011) (0)
- REM Sleep Behavior Disorder Is Associated with Reduced Alzheimer's Pathology, Hippocampal and Parietotemporal Atrophy in Dementia with Lewy Bodies (S44.006) (2013) (0)
- Editorial Board 2010 International Journal of Clinical and Experimental Pathology (ISSN 1936-2625). (2010) (0)
- Are Delays in Myelination Related to the Spinal Corticospinal Tract Degeneration of Pediatric AIDS Encephalomyelopathy (1990) (0)
- Mission Impossible: Integration of Metabolic and Degenerative Diseases (1996) (0)
- Early Diagnosis of Alzheimer's Disease (2000) (0)
- PATHOLOGIC INVESTIGATION OF MICROINFARCTS AND ASSOCIATION WITH GRAY MATTER ATROPHY ON ANTEMORTEM MRI (2014) (0)
- Neurocognitive Phenotypes across Frontotemporal Lobar Degeneration TDP-43 Subtypes (P05.067) (2012) (0)
- REPURPOSING FDG-PET AS A DIAGNOSTIC TOOL FOR ALZHEIMER’S-RELATED TDP-43-PROTEINOPATHY (2019) (0)
- Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility (2015) (0)
- Genome‐wide analysis identifies novel genetic variants and unique biological pathways associated with AD‐related proteins in the brain (2021) (0)
- Correlates of neuroimaging measures with pathological scales of cerebrovascular disease (2021) (0)
- Correlation between insulin-degrading enzyme levels and neuropathology in control versus Alzheimer brains with and without cerebral amyloid angiopathy (2010) (0)
- TMEM106B and hippocampal sclerosis in the elderly (2019) (0)
- Amyloid fibrils from frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) are composed of TMEM106B, rather than TDP-43 (2022) (0)
- Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation (2020) (0)
- S3-02-06 Neuropathology of conformational disorders: sporadic 4R taupathies (2004) (0)
- MAPPING REGULATORY VARIANTS IN THE ALZHEIMER'S DISEASE CANDIDATE GENE ABCA7 (2016) (0)
- Imaging-pathology correlations of cerebral white matter hyperintensities seen on postmortem MRI (2010) (0)
- 10 Corticobasal degeneration versus Picks' disease: An immunocytochemical comparison (1996) (0)
- Methylmap: visualization of modified nucleotides for large cohort sizes (2022) (0)
- P4-166 Age-associated periventricular white matter rarefaction does not correlate with clinical or pathologic evidence of vascular disease (2006) (0)
- P3-278 Increased tissue transglutaminase correlates with Alzheimer pathology and cognitive status (2004) (0)
- Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures (2022) (0)
- Using seeding models to understand strain differences from Alzheimer’s disease and pathological aging brains (2020) (0)
- Optimum differentiation of FTLD from AD achieved with cross‐sectional tau PET (2022) (0)
- S1-04-06 Alzheimer’s disease with amygdala Lewy bodies: A distinct form of Lewy body disease (2006) (0)
- Monoclonal Antibodies to A lzheimer Neurofibrillary Tangles 1 . Ident iJcation of Polypeptides (2007) (0)
- MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features (2020) (0)
- A genome-wide association study of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) (2010) (0)
- Coronin‐1a: A novel microglial marker for use in paraffin embedded tissue (2007) (0)
- An Extended Analysis of the Histological Variants of Tau‐Negative FTLD (2008) (0)
- Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis (2018) (0)
- Genome-wide association analysis of Dementia with Lewy bodies reveals unique genetic architecture (2017) (0)
- Evolution of core features in Lewy body disease pathologic subtypes (2021) (0)
- Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration (2021) (0)
- Infections of the nervous system clinical topics in infectious disease D. Schlossberg (Ed.), Springer-Verlag, New York, 1990, $106.00 (1991) (0)
- Molecular neuropathology of parkinsonism (2005) (0)
- Rapidly Progressive Dementia and Coma (2019) (0)
- P1-255: Neuropathological correlates of antemortem 1H MR spectroscopy in Alzheimer's disease (2008) (0)
- NEXT-GENERATION RNA SEQUENCING IN ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY (2014) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- GENE EXPRESSION PROFILING AND DNA METHYLATION IN ALZHEIMER'S DISEASE BRAINS (2014) (0)
- INTEGRATIVE SYSTEMS BIOLOGY APPROACH TO IDENTIFY NOVEL RISK FACTORS FOR PSP (2017) (0)
- ANALYSIS OF WILD TYPE AND R47H MUTANT TREM2 EXPRESSION IN ALZHEIMER'S DISEASE BRAINS (2016) (0)
- Quantitative characterization of brain β-amyloid in 718 normal subjects using a joint PiB/FDG PET image histogram (2016) (0)
- Pick's disease caused by a novel MAPT mutation (P1.216) (2015) (0)
- CLINICOPATHOLOGIC DIFFERENCES WITHIN ALZHEIMER’S DISEASE CASES FROM THE FLORIDA AUTOPSIED MULTI-ETHNIC (FLAME) STUDY (2018) (0)
- TRANSCRIPTIONAL REGULATION OF GENES AT THE ALZHEIMER'S DISEASE RISK LOCI (2014) (0)
- atrophy and posterior AD Late-onset Alzheimer disease genetic variants in posterior cortical (0)
- Diagnosis of Alzheimer's Disease and Tauopathies on Whole Slide Histopathology Images Using a Weakly Supervised Deep Learning Algorithm. (2023) (0)
- Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain (2017) (0)
- Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease (2022) (0)
- HDLS: Due to CSF1R Gene Mutation; Clinical Characteristics (P05.119) (2012) (0)
- Deregulation of AMPK activation in Alzheimer's disease and other tauopathies (2011) (0)
- Association between TDP-43 type and cognitive resilience to Alzheimer’s disease: a case-control study (2020) (0)
- TDP-43 Pathology in Alzheimer’s Disease (2021) (0)
- ANTEMORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON-FTLD OLDER ADULTS (2019) (0)
- Neuropathology of the Japanese variants of FTD/ALS (2006) (0)
- TMEM106B haplotypes have distinct gene expression patterns in aged brain (2018) (0)
- An MRI Atlas for Imaging and Pathologic Correlation Studies in Alzheimer’s Disease (S39.008) (2016) (0)
- IC-P1-034: Neuropathological correlates of antemortem 1H MR spectroscopy in Alzheimer's disease (2008) (0)
- Review Article TDP-43 in aging and Alzheimer's disease - a review (2011) (0)
- Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers (2019) (0)
- PATHOLOGIC PREDICTORS OF DISEASE DURATION IN LEWY BODY DISEASE (2016) (0)
- Mixed Alzheimer's and Lewy-related Pathology Can Cause Corticobasal Syndrome with Visual Hallucinations (2019) (0)
- P4-422 Mechanism of neurofibrillary degeneration in a mouse model of tauopathy and progress towards identification of a therapeutic target (2004) (0)
- Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells (2015) (0)
- Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease (2022) (0)
- Chapter 23 - Frontotemporal Dementia (2010) (0)
- Presence of co‐pathology in sporadic early‐onset Alzheimer disease versus dominantly inherited Alzheimer disease (2021) (0)
- ABI3 AND PLCG2 AS RISK FACTORS FOR ALZHEIMER'S DISEASE IN CAUCASIANS AND AFRICAN AMERICANS (2018) (0)
- 15 MICROGLIA IN CEREBELLAF. PLAQUES IN ALZHEIMERʼS DISEASE (1990) (0)
- Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s disease (2018) (0)
- APOE ε2 is associated with increased tau pathology in primary tauopathy (2018) (0)
- P1-367 COMPARISON OF IOFLUPANE-SPECT FINDINGSUSINGDATQUANT IN PATIENTS WITHALZHEIMER’S DISEASEDEMENTIA AND DEMENTIAWITH LEWY BODIES (2019) (0)
- TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A (2023) (0)
- ACCUMULATION OF ALZHEIMERʼS Aß PEPTIDE IN CULTURED VASCULAR SMOOTH MUSCLE CELLS IS ASSOCIATED WITH ALTERED ßAPP PROCESSING (1996) (0)
- STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECT OF APOE ε4 ON TAR DNA BINDING PROTEIN 43 (2018) (0)
- Detection of TDP-43 in Alzheimer disease and hippocampal sclerosis: 44.3 (2007) (0)
- Genetic analyses of SERPINA5 in Alzheimer’s disease (2021) (0)
- Neuroinflammation connecting amyloid‐beta and p‐tau pathology, may explain clinical heterogeneity in Alzheimer’s disease (2022) (0)
- Long-read sequencing across the C9orf72 ‘GGGGCC’ repeat expansion: implications for clinical use and genetic discovery efforts in human disease (2018) (0)
- A Kindred with Familial Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 (P05.058) (2012) (0)
- Explorer Criteria for the diagnosis of corticobasal degeneration (2015) (0)
- Single Cell Approaches Reveal Perturbed Brain Vascular Molecules in Alzheimer’s Disease (2022) (0)
- Correction to: ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD (2019) (0)
- An examination of atypical primary progressive aphasia variants (2021) (0)
- COMPARISON OF 123I-FP-CIT SPECT THREE QUANTIFICATION METHODS: A CLINICOPATHOLOGIC ANALYSIS IN 23 PATIENTS (2019) (0)
- Exploring alternative splicing and gene expression of load candidate genes in blood (2015) (0)
- Quantitative TDP‐43 burden and distribution in old age: High and low probability of Alzheimer’s disease and genetically confirmed FTLD‐TDP‐43 (2021) (0)
- Rare Genetic Risk in Progressive Supranuclear Palsy (2022) (0)
- Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains (2020) (0)
- Lessons learned from emerging mouse models of TDP-43 proteinopathy (2012) (0)
- Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy (2020) (0)
- FROM SYSTEMS LEVEL TRANSCRIPTOMICS TO NEW IMMUNE TARGETS FOR ALZHEIMER’S DISEASE (2016) (0)
- Immunoreactive keratin with foreign body reaction in anencephaly (2004) (0)
- Utility of ioflupane‐SPECT with multimodal imaging in dementia with Lewy bodies (2020) (0)
- FAMILIAL PICKʼS DISEASE-DOES IT REALLY EXIST? (1999) (0)
- SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia (2013) (0)
- Apoptosis intheBrain Physiology andPathology (1995) (0)
- High Resolution 1H MRI of Postmortem Human Brain Sections Performed at 21.1 T (2010) (0)
- Aging 6-2019 Limbic-Predominant Age-Related TDP-43 Encephalopathy ( LATE ) : Consensus Working Group Report (2019) (0)
- ANTE-MORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON-FTLD OLDER ADULTS (2019) (0)
- Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease (2022) (0)
- Integrative single‐nucleus RNAseq analysis identifies cell‐type‐specific expression perturbations in progressive supranuclear palsy (2022) (0)
- The novel p.K317N mutation in MAPT gene with clinicopathological phenotype of globular glial tauopathy (P2.161) (2015) (0)
- The many faces of globular glial tauopathy: A clinical and imaging study (2022) (0)
- Failure to Wean from a Ventilator Caused by ANNA-1 Seropositive Paraneoplastic Syndrome (2003) (0)
- Divergent impacts of C9orf72 repeat expansion on neurons and glia in ALS and FTD (2022) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures (2022) (0)
- P4-159 Neuropathology of mild cognitive impairment evolving into clinically probable dementia with Lewy bodies (2006) (0)
- P3-208: Genetic variation in PCDH11X associates with Alzheimer's disease in a two-stage GWAS study (2008) (0)
- The involvement of the 5lipoxygenase pathway in tauopathy (2015) (0)
- Expression of interleukin-1 receptors in human astrocytes (1994) (0)
- Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test (2014) (0)
- P3-175: Cognitive trajectories in hippocampal sclerosis, Alzheimer's disease, and vascular dementia: A pathology series from the Einstein Aging Study (EAS) brain bank (2008) (0)
- Western Blotting : A Guide to Current Methods Introductions (0)
- IRON PROMOTES ACCUMULATION OF β-AMYLOID PROTEIN IN CULTURED VASCULAR SMOOTH MUSCLE CELLS: 84 (1995) (0)
- MULTICYSTIC ENCEPHALOPATHY: LIGHT MICROSCOPIC AND IMHUNOCYTOCHEHICAL STUDY OF SEVEN CASES WITH CLINICAL CORRELATION (1993) (0)
- degeneration progressive supranuclear palsy and corticobasal gene in tau haplotype association analysis of the Linkage disequilibrium fine mapping and (2005) (0)
- INTEGRATIVE GENOMIC PROFILING TO IDENTIFY GENES AND PATHWAYS ASSOCIATED WITH VASCULAR RISK IN AD (2019) (0)
- TDP-43 mouse models: Tools toward understanding the normal and disease roles for TDP-43 (2010) (0)
- Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer’s Disease and APPswe/PS1dE9 Double Transgenic Mice Brains (2015) (0)
- A quantitative study of neuronal loss and transgene expression in mutant tau transgenic mice (2002) (0)
- Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications (2012) (0)
- Use of a wild-type tauopathy model to generate a novel Alzheimer model (2009) (0)
- 2.115 Perry's syndrome is a unique TDP-43 proteinopathy (2007) (0)
- Clinical-Imaging-Pathologic Analysis in Seven Patients with Dementia: Correlations with Ioflupane SPECT Findings (P6.236) (2016) (0)
- Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants (P05.069) (2012) (0)
- Investigating gene expression changes underlying selective hippocampal vulnerability in Alzheimer’s disease using a translational neuropathology approach (2020) (0)
- P4-036 Is family history of dementia a risk factor for lewy body dementia (2004) (0)
- Patterns of regional brain atrophy and amyloid deposition in Alzheimer's disease (2013) (0)
- CHARACTERIZATION OF MICROGLIA IN HUMAN FETAL CERVICAL SPINAL CORD: 66 (1990) (0)
- Frontal lobe dementia with novel tauopathy (2001) (0)
- S 22-3 Chronic Traumatic Encephalopathy in Athletes : The Aftermath of Repetitive Head Injuries (2018) (0)
- Characterizing neurofibrillary tangle maturity of phosphorylated tau fluid biomarkers in Alzheimer's disease (2021) (0)
- Heterogeneity of Tau Proteins in Alzheimer's Disease Evidence for Increased Preferential Distribution Neurites Expression of an Isoform and of a Phosphorylated Isoform in (2007) (0)
- Authors' response to commentaries (1995) (0)
- Tau exhibits unique seeding properties in globular glial tauopathy (2019) (0)
- Title Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy : A case control study (2012) (0)
- APOE2 Exacerbates TDP‐43 Related Toxicity in the Absence of Alzheimer Pathology (2022) (0)
- Mixed Alzheimer's and Lewy body disease pathology patterns (2010) (0)
- Identification of a Novel Risk Locus for Progressive Supranuclear Palsy by a Pooled Genomewide Scan of 500,288 Single-Nucleotide Polymorphisms (2007) (0)
- P2-070 Axonal degeneration in P301L Tau transgenic mice (2004) (0)
- Mayo Clinic Florida Morris K. Udall Center of Excellence for Parkinson's Research (2016) (0)
- P3-163 Identification of a novel risk gene for progressive supranuclear palsy by a genome-wide scan of 500,288 SNPs (2006) (0)
- 69 An antibody to an amino-terminal domain of presenilin-1 immunostains neurofibrillary tangles in Alzheimer's disease (1996) (0)
- PRODUCTION OF VASCULAR ALZHEIMERʼS AMYLOID-β IS ASSOCIATED WITH A DECRESED EXPRESSION OF ERAB (L-3-HYDROXYACYL-COENZYME A DEHYDROGENASE) (1999) (0)
- Pathology‐related alterations in gene expression in Alzheimer’s disease: Single cell resolution (2021) (0)
- Investigation of differentially expressed proteins through neurofibrillary tangle maturation in Alzheimer’s disease using NanoString’s GeoMx Digital Spatial Profiler (2022) (0)
- FP-CIT SPECT and neuropathologic findings amongpatients with neurodegenerative syndromes from the Mayo Alzheimer’s Disease (2019) (0)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
- Neuropathological evidence of heterogeneity (2012) (0)
- Cellular and pathological heterogeneity of primary tauopathies (2021) (0)
- Rapidly Progressive Cerebellar Ataxia and Dementia due to Cortical Cerebellar and Thalamic Degeneration: A Case Series of Two Autopsy Confirmed Patients (P8-11.016) (2023) (0)
- The coarse‐grained plaque is an Aβ plaque‐type in APOE Ɛ4+ Alzheimer’s disease that is associated with astrogliosis and p‐tau burden (2022) (0)
- Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts (2023) (0)
- Induction of mutant tau expression in aged rTg4510 mice does not rapidly induce tauopathy (2009) (0)
- COMPARISON OF IOFLUPANE-SPECT FINDINGS USING DATQUANT IN PATIENTS WITH ALZHEIMER’S DISEASE DEMENTIA AND DEMENTIA WITH LEWY BODIES (2019) (0)
- TAU PET IMAGING CORRELATES WITH NEUROPATHOLOGY (2019) (0)
- Progranulin gene polymorphism (GRN rs5848) that is associated with FTLD-U is increased in African-Americans and shows a tendency to correlate with cognitive performance in subjects enrolled in the Einstein Aging Study (2009) (0)
- Expression QTL Studies in LOAD and PSP Brains by Next-Generation RNA Sequencing (P2.147) (2014) (0)
- ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans (2018) (0)
- An enrichment of rare variants and the lysosomal pathways are important contributors to early onset Alzheimer disease (2021) (0)
- Explorer Concordant Association of Insulin Degrading Enzyme Gene ( IDE ) Variants with IDE mRNA , A beta , and Alzheimer ' s Disease (2017) (0)
- 9 Neuropathology of Parkinsonism (2005) (0)
- Paired Helical Filament from Alzheimer's Disease Human Brain Tissue (2020) (0)
- Elevated granulocyte colony stimulating factor (CSF) causes cerebellar deficits and anxiety in a model of CSF‐1 receptor related leukodystrophy (2022) (0)
- Correction to: Apolipoprotein E regulates lipid metabolism and α‑synuclein pathology in human iPSC‑derived cerebral organoids (2021) (0)
- Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging (American Journal of Pathology (2010), 177, (311-324)) (2010) (0)
- TDP-43 DRIVES FASTER RATES OF HIPPOCAMPAL ATROPHY IN ALZHEIMER’S DISEASE STARTING AT LEAST 10 YEARS PRIOR TO DEATH (2017) (0)
- O4-05-01 Methods of cell death and recovery in the rTg4510 and iP301L inducible mouse models of tauopathy (2006) (0)
- O1-02-03: Antemortem MRI–based structural abnormality index (STAND) scores correlate with postmortem Alzheimer disease Braak stages (2008) (0)
- Analysis of COQ2gene in multiple system atrophy (2014) (0)
- Antemortem MRI findings associated with presence of microinfarcts at autopsy (2013) (0)
- Erratum to Letters to the Editor regarding: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9. (2022) (0)
- Investigating cis-SNP/mRNA level associations of candidate Alzheimer genes in different brain regions of patients and controls (2010) (0)
- P3-275: Genome-wide association study for Braak neurofibrillary tangle (NFT) staging (2008) (0)
- STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECTOFAPOE ε 4ONTARDNABINDING PROTEIN 43 (2018) (0)
- Identification of human disease-associated variants in a brain expression genome-wide association study (eGWAS) (2012) (0)
- Co‐existence of diffuse multisystem tauopathy and cerebral amyloid angiopathy in an elderly patient with dementia (2008) (0)
- Neuropathology, Genetics and Biomarkers of Synucleinopathies (2021) (0)
- P3-027: Hippocampal sclerosis and TDP-43 immunoreactivity: A clinicopathological study (2008) (0)
- Clinical Predictors of Survival in Probable Dementia with Lewy Bodies (P13-6.006) (2023) (0)
- 96. Diagnosing amyotrophic lateral sclerosis in patients with hereditary neuropathy (2008) (0)
- Hippocampal sclerosis (HpScl) in the elderly with dementia: Clinical, genetic and pathologic findings (2009) (0)
- Report of A Family with Adult‐Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Without Mutations in CSF1R, AARS1 or AARS2 (2022) (0)
- Clinico-radiologic and Pathological Evaluation of Corticobasal Syndrome (S8.004) (2023) (0)
- S2-02-06 The tauopathies: From genetics to animal models (2006) (0)
- PAIRED HELICAL FILAMENTS (PHF) IN CORTICOBASAL DEGENERATION (1993) (0)
- Diagnosis of Alzheimer’s Disease and Tauopathies on Whole Slide Images using Deep Learning Algorithm (S39.001) (2023) (0)
- Digital Pathology Investigation of SERPINA5‐Tau Protein Interaction in Alzheimer’s Disease and Primary Tauopathies (2022) (0)
- Straight Filament from Alzheimer's Disease Human Brain Tissue (2020) (0)
- P3-216: Identification of CIS variants associating with expression levels of 12 late-onset Alzheimer's disease (LOAD) candidate genes in a Genome-Wide Association Study (GWAS) (2008) (0)
- DISTINCT ULTRASTRUCTURAL CHARACTERISTICS OF CAPILLARY BASAL LAMINA IN HUMAN AND MOUSE BRAINS: RELEVANCE TO MURINE MODELS OF NEUROVASCULAR DISEASE (2017) (0)
- P3-258: Further evidence of genetic association between SORL1 and Alzheimer's disease (2008) (0)
- Creutzfeldt–Jakob Disease Misdiagnosed as Multiple System Atrophy (2023) (0)
- FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP (2013) (0)
- Neurons during early development are highly vulnerable to TDP-43 dysregulation (2011) (0)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (0)
- Genetic association of progressive supranuclear palsy (PSP) risk loci variants with brain gene expression and neuropathology endophenotypes (2012) (0)
- Identification of Novel Modifiers of Tau Aggregation and Pathology using a Proximity Proteomics Approach (2022) (0)
- The functional impact of cerebral white matter hyperintensities in the elderly (2009) (0)
- Haplotypes at the MAPT locus associate with risk for LOAD and brain gene expression (2013) (0)
- LRRK2 modulation of neuropathology in a mouse model of tauopathy (2012) (0)
- Semi-quantitative PCR based screening of α -Synuclein multiplication in multiple system atrophy (2008) (0)
- The lysosomal protein cathepsin L is a progranulin protease (2017) (0)
- Poster Presentations: P2 P391 P2-124 ABERRANT TAU AND AMYLOID PATHOLOGY UNDERLIE 1H MR SPECTROSCOPIC ALTERATIONS IN ALZHEIMER’S DISEASE AND LEWY BODY DISEASE (2013) (0)
- A novel clinicopathologic entity causing rapidly progressive cerebellar ataxia? (2022) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Infarctions on antemortem MRI are associated with the presence of microinfarcts at autopsy (2012) (0)
- Regional and whole-brain atrophy rates in autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease (2013) (0)
- Antemortem MRI findings associated with presence of microinfarcts at autopsy (2013) (0)
- Evaluation of known Alzheimer's genes for SNPs that influence their brain expression (eSNPs) (2011) (0)
- Aberrant tau and amyloid pathology underlies 1H MR spectroscopic alterations in Alzheimer's disease and Lewy body disease (2013) (0)
- Precursor Protein Transgenic b Amyloid Attenuates Amyloid Plaque Deposition in Promotes Complement Expression and g IFN-and (2010) (0)
- P1-117 Kinetics of tau suppression in the rTg4510 inducible model of tauopathy (2006) (0)
- P4-167: Investigation of mitochondrial DNA damage in late-onset Alzheimer's disease (2008) (0)
- Wild-type human TDP-43 induces mitochondrial abnormalities and axonal degeneration in transgenic mice (2010) (0)
- Erratum: Differentiating clinicopathologic and genetic aspects of hippocampal sclerosis in Alzheimer's disease from limbic predominant Alzheimer's disease and "pure" hippocampal sclerosis, (Alzheimer's and Dementia) (2012) (0)
- Phenotype of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia with ALS (FTD/ALS) Associated with the GGGGCC Repeat Expansion in C9ORF72 (c9FTD/ALS) (IN9-1.004) (2012) (0)
- Poster Presentations: P1 P193 P1-116 NEUROPROTECTIVE ROLES OF ONCOPROTEIN MDMX IN MODELS OFALZHEIMER’S DISEASE (2013) (0)
- Aberrant tau and amyloid pathology underlie 1H MR spectroscopic alterations in Alzheimer's disease and Lewy body disease (2013) (0)
- Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) (0)
- Association study of late-onset Alzheimer's disease risk variants and risk for posterior cortical atrophy (2013) (0)
- Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study (2021) (0)
- IMMUNOCYTOCHEMICAL STUDIES OF GLIOFIBRILLARY INCLUSIONS IN LIPIDIZED ASTROCYTES OF THE INFANT BRAIN (1993) (0)
- Perry disease – expanding the genetic basis (2023) (0)
- Vascular and Alzheimer's Disease pathologies in relation to cognitive decline: Data from the Einstein Aging Study Autopsy series (2011) (0)
- Antemortem increase in gray matter diffusivity is associated with decreased neuronal density (2011) (0)
- Astrocyte-derived clusterin suppresses amyloid formation in vivo (2020) (0)
- O2-06-04: Identification of late-onset Alzheimer's disease (LOAD) susceptibility alleles in the PAI-1 gene (2008) (0)
- Neuropathology of Parkinson’s disease after focused ultrasound thalamotomy (2022) (0)
- Antemortem increase in gray matter diffusivity is associated with decreased neuronal density (2011) (0)
- RBD Is Associated with Reduced Alzheimer's Pathology in Dementia with Lewy Bodies (P05.050) (2012) (0)
- COMPARISON OF 123I-FP-CIT SPECT THREE QUANTIFICATION METHODS: A CLINICOPATHOLOGIC ANALYSIS IN 23 PATIENTS (2019) (0)
- P3-271: Association of candidate gene susceptibility alleles on chromosome 10 with Alzheimer's disease risk and endophenotypes (2008) (0)
- High resolution MRI at 21 . 1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer ’ s Disease and Diffuse Lewy Body Disorder (2011) (0)
- Infarctions on antemortem MRI are associated with the presence of microinfarcts at autopsy (2012) (0)
- A Family With Corticobasal Degeneration, Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Dementia (P3.085) (2014) (0)
- A DOUBLE-LABELING IMMUNOHISTOCHEMICAL STUDY OF A TAU EXON 10 EPITOPE IN ALZHEIMERʼS DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY (1999) (0)
- IsThere aNon-Amyloid Precursor toSenile Plaques? (1997) (0)
- REGIONAL DISTRIBUTION OF AMYLOID-BETA, SOLUBLE APP AND SYNAPTIC MARKERS IN HUMAN BRAINS (2016) (0)
- Frontemporal dementia mutations in MAPT cause chromosome mis-segregation and aneuploidy including trisomy 21 (2013) (0)
- Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders (2008) (0)
- FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP (2013) (0)
- Clinical and pathological studies of olfactory dysfunction in FTDP-17 (PPND Family with N279K MAPT mutation) (2008) (0)
- Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation (2022) (0)
- Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis (2007) (0)
- Mammillary body atrophy in the differential diagnosis of hippocampal atrophy (2009) (0)
- O2-17-06 SAFETYAND TOLERABILITY OF CRENEZUMAB IN MILD-TO-MODERATE AD PATIENTS TREATEDWITH ESCALATING DOSES FOR UP TO 25 MONTHS (2017) (0)
- Evidence of cerebellar TDP-43 loss of function in FTLD-TDP (2022) (0)
- PSEN1 M233V MUTATION CAUSES VERY EARLY ONSET ALZHEIMER DISEASE: THE IMPORTANCE OF NEUROPATHOLOGIC ARCHIVAL TISSUE (2014) (0)
- Contents Vol. 17, 2004 (2004) (0)
- Pathological analysis of ErbB family and NRG-1 protein in progressive supranuclear palsy (2019) (0)
- A REGULATORY VARIANT AT THE TREM GENE CLUSTER ASSOCIATES WITH DECREASED ALZHEIMER’S DISEASE RISK AND INCREASED TREML1 AND TREM2 BRAIN GENE EXPRESSION (2016) (0)
- Central Nervous System in Pediatric HIV Infection: A Multicenter Study1 (1990) (0)
- Astrocytes Inhibit Cryptococcus Neos Growth by a Nitric Oxide-mediated Mechanism (2003) (0)
- Pathological Aging in Africans: A Benign Form of Cerebral Amyloidosis vs. Pre‐Clinical Alzheimer's Disease? (1996) (0)
- Plasma Biomarkers of Amyloid and Neurodegeneration predictive of Neuropathologic Scales of Cerebrovascular Disease (2022) (0)
- Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease (2021) (0)
- EARLY, BUT NOT ADVANCED, NEUROFIBRILLARY TANGLE PATHOLOGY OR AMYLOID-B PATHOLOGY SIGNIFICANTLY ASSOCIATES WITH ABNORMAL HIPPOCAMPAL SIZE IN COGNITIVELY NORMAL ELDERLY (2014) (0)
- CONVERGENT ANALYSIS OF ENDOPHENOTYPES IN PROGRESSIVE SUPRANUCLEAR PALSY (2016) (0)
- RETROSPECTIVE REVIEW OF CLINICAL FEATURES OF ABCA7 LOSS-OF-FUNCTION MUTATION CARRIERS IN LATE-ONSET ALZHEIMER’S DISEASE (2019) (0)
- Immunoelectron microscopy of TDP‐43 in frontotemporal lobar degeneration, amyotrophic lateral sclerosis and Lewy body disease (2008) (0)
- Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dennis W. Dickson?
Dennis W. Dickson is affiliated with the following schools:
